Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 3211
interventional 2695
Observational 473
Registry 43

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 1051
Radiation 193
Procedure 156
Behavioral 126
Other 124
Drug|placebo 122
Device 119
Biological 102
Drug|Radiation 81
Drug|Other 63
Drug|Procedure 63
Biological|Drug 56
Diagnostic Test 39
Dietary Supplement 28
Dietary Supplement|placebo 22
Other|Procedure 18
Drug|Procedure|Radiation 16
Procedure|Radiation 15
Behavioral|Other 14
Device|Drug 14
Device|Procedure 14
Drug|Other|Procedure 14
Other|Procedure|Radiation 14
Other|Radiation 14
Drug|Other|Radiation 13
Biological|Drug|Other 11
Dietary Supplement|Drug 10
Biological|Other 9
Biological|placebo 9
Drug|Other|placebo 8
Biological|Drug|placebo 6
Device|Other 6
Behavioral|Drug 5
Behavioral|Radiation 5
Biological|Drug|Procedure 5
Biological|Procedure 5
Biological|Radiation 5
Diagnostic Test|Drug 5
Dietary Supplement|Other 5
Drug|placebo|Radiation 5
Genetic 5
Biological|Other|Procedure 4
Device|Radiation 4
Dietary Supplement|Other|Procedure 4
Behavioral|Dietary Supplement|Other 3
Behavioral|Other|Procedure 3
Biological|Drug|Other|Procedure 3
Biological|Drug|Radiation 3
Combination Product 3
Combination Product|Drug 3
Dietary Supplement|Drug|placebo 3
Dietary Supplement|Procedure 3
Drug|Other|placebo|Procedure 3
Behavioral|Drug|Other|placebo 2
Behavioral|Procedure 2
Biological|Device 2
Biological|Device|Other|Procedure 2
Biological|Drug|Genetic|Other 2
Biological|Drug|Other|placebo 2
Device|Other|Procedure 2
Dietary Supplement|Drug|Other|placebo 2
Dietary Supplement|Drug|Radiation 2
Drug|Genetic|Other 2
Drug|Other|Procedure|Radiation 2
Behavioral|Device 1
Behavioral|Device|Other|Procedure|Radiation 1
Behavioral|Dietary Supplement|Drug|Other|Procedure 1
Behavioral|Dietary Supplement|Other|placebo 1
Behavioral|Dietary Supplement|Other|Procedure 1
Behavioral|Dietary Supplement|Procedure 1
Behavioral|Genetic 1
Behavioral|Genetic|Other|Procedure 1
Behavioral|Other|Procedure|Radiation 1
Behavioral|placebo 1
Biological|Device|Drug 1
Biological|Device|Drug|Procedure 1
Biological|Drug|placebo|Procedure 1
Biological|Other|placebo 1
Biological|Other|Radiation 1
Combination Product|Procedure 1
Combination Product|Radiation 1
Device|Diagnostic Test|Other 1
Device|Diagnostic Test|Other|Procedure 1
Device|Drug|Other 1
Device|Drug|Procedure 1
Device|Drug|Radiation 1
Device|Procedure|Radiation 1
Diagnostic Test|Drug|Other|Procedure 1
Diagnostic Test|Other 1
Diagnostic Test|Other|placebo 1
Diagnostic Test|Other|Procedure 1
Diagnostic Test|Radiation 1
Dietary Supplement|Drug|Other|placebo|Procedure 1
Dietary Supplement|Drug|Other|Procedure 1
Dietary Supplement|Drug|Procedure 1
Dietary Supplement|Other|placebo|Procedure 1
Dietary Supplement|placebo|Procedure 1
Dietary Supplement|Radiation 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Procedure 1
Drug|Genetic|Radiation 1
Drug|placebo|Procedure 1
Genetic|Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 1425
Canada 201
NA 90
France 82
United Kingdom 72
United States|Canada 63
China 49
Denmark 41
Germany 40
Italy 28
Japan 28
Netherlands 28
Korea, Republic of 27
Finland 25
Australia 21
Sweden 17
Switzerland 17
Brazil 16
Norway 16
Belgium 15
Spain 14
United States|United Kingdom 12
Israel 11
Hong Kong 7
United States|Puerto Rico 7
Czechia 6
Russian Federation 5
Taiwan 5
Turkey 5
Austria 4
Belgium|Netherlands 4
India 4
Ireland 4
Portugal 4
Singapore 4
Australia|New Zealand 3
Greece 3
Poland 3
South Africa 3
Austria|Germany 2
Belgium|France 2
Czech Republic|United Kingdom 2
Denmark|Finland|Norway|Sweden 2
Germany|Switzerland 2
Iran, Islamic Republic of 2
Moldova, Republic of 2
Saudi Arabia 2
Switzerland|United Kingdom 2
United States|Australia 2
United States|Australia|Belgium|Canada|Denmark|France|Germany|Ireland|Israel|Italy|Spain|United Kingdom 2
United States|Australia|Canada 2
United States|Canada|Czech Republic|Germany|Hungary|Mexico|Netherlands|Puerto Rico|Romania|Russian Federation|Ukraine|United Kingdom 2
United States|Canada|Puerto Rico 2
United States|Canada|Spain|United Kingdom 2
United States|Canada|Switzerland 2
United States|Czech Republic|Estonia|Finland|France|United Kingdom 2
United States|Finland 2
United States|Mexico 2
United States|Netherlands|United Kingdom 2
United States|South Africa 2
United States|Spain 2
Argentina|Austria|Belgium|Brazil|Czechia|France|Hungary|Israel|Italy|Japan|Latvia|Lithuania|Panama|Peru|Poland|Russian Federation|South Africa|Spain|Ukraine 1
Australia|Austria|Belgium|Czech Republic|Germany|Hungary|Ireland|Israel|Italy|Mexico|Netherlands|Poland|Portugal|South Africa|Spain|United Kingdom 1
Australia|Belgium|Brazil|Poland|Portugal|Romania|Argentina|Bulgaria|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Australia|Belgium|Canada|Chile|Czech Republic|France|Italy|Mexico|Netherlands|Poland|Portugal|Spain|United Kingdom 1
Australia|Belgium|Germany|Italy|Netherlands|Norway|Spain|Switzerland 1
Australia|Brazil|China|Korea, Republic of|Kuwait|Lebanon|New Zealand|Saudi Arabia|Taiwan|Thailand 1
Australia|Canada|France 1
Australia|Georgia|New Zealand 1
Australia|Hong Kong|Singapore 1
Australia|United States|Argentina|Belgium|Canada|Chile|Czechia|Finland|France|Germany|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
Australia|United States|Austria|Belgium|Canada|France|Germany|Ireland|Italy|Netherlands|Puerto Rico|Spain|Sweden|United Kingdom 1
Australia|United States|Belgium|Canada|France|Germany|Greece|Netherlands|Spain|Sweden|United Kingdom 1
Austria|Belgium|Czechia|France|Germany|Greece|Iceland|Ireland|Italy|Netherlands|Norway|Spain|United Kingdom 1
Austria|Belgium|Denmark|France|Israel|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom 1
Austria|France|Netherlands|United Kingdom 1
Austria|Germany|Switzerland 1
Belgium|Canada|Denmark|France|Ireland|Italy|Norway|Poland|Spain|Switzerland|United Kingdom 1
Belgium|Cyprus|Czech Republic|France|Ireland|Italy|Luxembourg|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Czech Republic|Finland|France|Germany|Hungary|Italy|Russian Federation|Slovakia|Spain 1
Belgium|Czechia|Denmark|Germany 1
Belgium|Czechia|Germany|Hungary|Italy|Poland|Spain 1
Belgium|Denmark|Finland|Italy|Norway|Portugal|Sweden|Turkey 1
Belgium|Denmark|France|Germany|Italy|Spain|Switzerland|United Kingdom 1
Belgium|Denmark|France|Italy|Latvia|Lithuania|Netherlands|Romania|Spain|United Kingdom 1
Belgium|Denmark|Italy|Netherlands|Poland|Portugal|Russian Federation|Switzerland|United Kingdom 1
Belgium|Finland|France|Germany|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Finland|France|Germany|Montenegro|Netherlands|Romania|Russian Federation|Serbia|United Kingdom 1
Belgium|Finland|Israel|Netherlands|Portugal|Spain|Switzerland|Turkey 1
Belgium|France|Germany|Israel|Spain|Switzerland 1
Belgium|France|Germany|Italy|Netherlands|Spain 1
Belgium|France|Germany|Spain|United Kingdom 1
Belgium|France|Ireland|Italy|Romania|Spain|Switzerland 1
Belgium|France|Italy|Portugal|Spain|Sweden|Turkey 1
Belgium|Germany 1
Belgium|Germany|Hungary|Netherlands|Poland|Romania|Russian Federation|South Africa 1
Belgium|Germany|Hungary|Netherlands|Romania|Russian Federation|South Africa 1
Belgium|Germany|Hungary|United Kingdom 1
Belgium|Germany|Switzerland 1
Belgium|Italy|Slovakia 1
Belgium|Luxembourg 1
Belgium|Spain 1
Belgium|United States|Argentina|Croatia|France|Germany|Hungary|Israel|Italy|Netherlands|Peru|Poland|Russian Federation|Spain|United Kingdom 1
Brazil|Germany|Hungary|South Africa|Sweden 1
Brazil|United States|Argentina|Australia|Austria|Belgium|Canada|Chile|Colombia|Czech Republic|Denmark|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Mexico|Netherlands|Peru|Poland|Puerto Rico|Romania|Russian Federation|Spain|United Kingdom 1
Bulgaria|France|Latvia|Poland|Romania 1
Canada|Belgium|Czech Republic|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Mexico|Netherlands|Norway|Poland|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Canada|China|Korea, Republic of|United Kingdom 1
Canada|Finland|Lithuania 1
Canada|France|India|Italy|Malaysia|Russian Federation 1
Canada|France|United Kingdom 1
Canada|Georgia 1
Canada|Israel|Italy|Singapore|United Kingdom 1
Canada|United Kingdom 1
Canada|United States 1
China|Hong Kong|Korea, Republic of|Taiwan 1
China|Korea, Republic of|Singapore|Taiwan 1
China|Malaysia|Russian Federation|Thailand 1
China|Russian Federation 1
China|United States|Argentina|Belgium|Brazil|Canada|Czechia|France|Germany|Israel|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Croatia 1
Cuba 1
Cyprus 1
Czech Republic 1
Denmark|Estonia|Finland 1
Denmark|Finland|France 1
Denmark|Finland|Hungary|Norway|Romania|Russian Federation|Sweden 1
Denmark|Finland|Netherlands|Sweden 1
Denmark|Germany 1
Denmark|United Kingdom 1
Denmark|United States|Argentina|Australia|Brazil|Canada|Chile|Colombia|Czech Republic|France|Germany|Greece|Hungary|Italy|Mexico|Netherlands|Norway|Poland|Puerto Rico|Romania|Spain|Sweden|Turkey|United Kingdom 1
Egypt 1
Estonia|Finland|France|Germany|Netherlands|Russian Federation|Spain|Sweden|United Kingdom 1
Estonia|Finland|Latvia|Sweden 1
Finland|France|Germany 1
Finland|France|Latvia|United Kingdom 1
Finland|France|United Kingdom 1
Finland|Germany|Switzerland 1
Finland|Hungary 1
Finland|Ireland|Sweden 1
Finland|Norway|Sweden|United Kingdom 1
Finland|Sweden 1
France|Germany|Netherlands 1
France|Germany|Switzerland 1
France|Guadeloupe 1
France|Guadeloupe|Martinique 1
France|Italy|Spain|Switzerland 1
France|Netherlands|United Kingdom 1
France|United States|Australia|Austria|Brazil|Canada|Denmark|Finland|Italy|Korea, Republic of|Netherlands|Poland|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
France|United States|Australia|Belgium|Brazil|Canada|Chile|China|Czechia|Germany|Italy|Japan|Korea, Republic of|Netherlands|Slovakia|Spain|Turkey|United Kingdom 1
Georgia|Russian Federation 1
Germany|Greece|India|Israel|Italy|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Czech Republic|Estonia|France|Korea, Republic of|Latvia|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Panama|Peru|Poland|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Germany|Hungary|United Kingdom 1
Germany|Italy 1
Germany|Poland 1
Greece|Spain 1
Hong Kong|Indonesia|Malaysia|Philippines|Singapore|Taiwan|Thailand|Vietnam 1
Hungary 1
Iceland 1
Ireland|Israel|Italy|Japan|Hong Kong|United States|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Czech Republic|Finland|France|Germany|Greece|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Ireland|Netherlands|Spain|United States|Australia|Austria|Belgium|Canada|France|Germany|Hungary|United Kingdom 1
Ireland|United Kingdom 1
Israel|Belgium|Malta|Netherlands|Russian Federation|Turkey|United Kingdom 1
Italy|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Croatia|Czech Republic|Denmark|Finland|Hungary|India|Ireland|Kazakhstan|Luxembourg|Malaysia|Mexico|Philippines|Poland|Portugal|Romania|Serbia|Singapore|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
Italy|Austria|Belgium|Czechia|France|Germany|Greece|Netherlands|Norway|Poland|Russian Federation|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Italy|Spain 1
Italy|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Russian Federation|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Japan|United States|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|Finland|France|Germany|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
Korea, Republic of|Taiwan 1
Latvia 1
Lithuania 1
Malaysia 1
Mexico|Panama|Peru 1
Mexico|Poland|Romania|United States|Argentina|Australia|Brazil|Canada|China|Czechia|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Moldova, Republic of|Spain 1
Netherlands|United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Japan|Korea, Republic of|Mexico|Russian Federation|South Africa|Spain|United Kingdom 1
Netherlands|United States|Austria|Belarus|Belgium|Bulgaria|Croatia|Czechia|Denmark|France|Germany|Hungary|Italy|Latvia|Lithuania|Poland|Portugal|Serbia|Slovakia|Spain|Sweden|United Kingdom 1
Nigeria 1
Norway|Sweden 1
Pakistan 1
Peru|United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|France|Germany|Hungary|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Tunisia|Turkey|United Kingdom 1
Slovakia|United States|Australia|Belgium|Denmark|Finland|France|Italy|Spain|Sweden|United Kingdom 1
South Africa|United Kingdom 1
Sweden|United Kingdom 1
United Kingdom|United States|Belgium|Denmark|Sweden 1
United States|Argentina 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Italy|Japan|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Tunisia|Turkey|Ukraine|United Kingdom| 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Colombia|Czechia|Estonia|Finland|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|Mexico|New Zealand|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Taiwan|Denmark|Finland|France|Germany|Greece|Hong Kong|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Singapore|Slovakia|Spain|Sweden|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Serbia|Singapore|South Africa|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Colombia|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|France|Germany|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|China|Denmark|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|Norway|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Chile|Czechia|Denmark|Finland|France|Georgia|Germany|Israel|Italy|Korea, Republic of|Moldova, Republic of|New Zealand|Poland|Russian Federation|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Chile|Denmark|Finland|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Chile|Colombia|France|Germany|Mexico|Spain 1
United States|Argentina|Australia|Brazil|Canada|China|Czechia|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Czech Republic|Finland|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Mexico|Norway|Peru|Poland|Romania|Russian Federation|South Africa|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Czech Republic|Finland|France|Germany|Hungary|India|Italy|Korea, Republic of|Netherlands|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|China|France|Germany|Greece|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Peru|Poland|Portugal|Romania|Russian Federation|Spain|Switzerland|Taiwan|Thailand|Turkey 1
United States|Argentina|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|Finland|France|Germany|Hungary|India|Italy|Korea, Republic of|Mexico|Netherlands|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Costa Rica|Denmark|France|Greece|Hungary|Russian Federation|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Norway|Poland|Portugal|Spain|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|Denmark|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Russian Federation|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Greece|Ireland|Italy|Netherlands|New Zealand|Poland|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Greece|Ireland|Italy|Netherlands|New Zealand|Poland|South Africa|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Belgium|France|Netherlands 1
United States|Australia|Austria|Belgium|Ireland|New Zealand|Slovenia|Spain|United Kingdom 1
United States|Australia|Austria|Brazil|Canada|France|Germany|India|Israel|Italy|Mexico|Netherlands|Poland|Russian Federation|South Africa|Turkey|United Kingdom 1
United States|Australia|Austria|Canada|Denmark|France|Germany|Italy|Poland|Spain 1
United States|Australia|Austria|Chile|Colombia|Denmark|France|Germany|Israel|Japan|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|Taiwan 1
United States|Australia|Belarus|Brazil|Canada|China|Czechia|Denmark|Finland|France|Germany|Israel|Italy|Japan|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine 1
United States|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|Finland|France|Germany|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czech Republic|France|Germany|Hong Kong|Israel|Italy|Netherlands|Norway|Poland|Singapore|Slovakia|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Denmark|France|Israel|Korea, Republic of|Netherlands|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Finland|France|Germany|Israel|Italy|Japan|Netherlands|Norway|Poland|Russian Federation|Singapore|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Estonia|Finland|France|Greece|Hungary|Italy|Netherlands|Poland|Spain 1
United States|Australia|Belgium|Canada|Denmark|Estonia|France|Germany|Iceland|Israel|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|Finland|France|Indonesia|Netherlands|Norway|Poland|Sweden|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Netherlands|Poland|Russian Federation|Slovakia|South Africa|Spain 1
United States|Australia|Belgium|France|Germany|Italy|Singapore|Spain 1
United States|Australia|Belgium|Germany|Spain|Sweden|United Kingdom 1
United States|Australia|Brazil|Canada|Chile|Czechia|France|Germany|Israel|Italy|Korea, Republic of|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Bulgaria|Canada|Czechia|France|Greece|Hungary|India|Latvia|Mexico|New Zealand|Poland|Russian Federation|Slovakia|Slovenia|South Africa|Ukraine 1
United States|Australia|Canada|China|Germany|Ireland|Netherlands|United Kingdom 1
United States|Australia|Canada|Czech Republic|France|Hungary|Russian Federation|United Kingdom 1
United States|Australia|Canada|Ireland|New Zealand|United Kingdom 1
United States|Australia|Canada|Spain|United Kingdom 1
United States|Australia|Chile|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|Denmark|Germany|Korea, Republic of|Netherlands|Puerto Rico|Romania|Spain|United Kingdom 1
United States|Australia|Italy 1
United States|Australia|Italy|Korea, Republic of|Spain 1
United States|Australia|Peru|Puerto Rico 1
United States|Australia|Puerto Rico|Spain 1
United States|Australia|Slovakia|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Israel|Italy|Japan|Korea, Republic of|Lithuania|Netherlands|Poland|Russian Federation|Singapore|Spain|Sweden|United Kingdom 1
United States|Austria 1
United States|Austria|Belgium|Germany|India|Netherlands|Poland|Russian Federation|South Africa|United Kingdom 1
United States|Austria|Czech Republic|Germany|Hungary|Italy|Slovakia|Spain|United Kingdom 1
United States|Austria|Czechia|Germany|Lithuania|Poland|Slovakia|Taiwan 1
United States|Belgium|Canada|Czech Republic|Finland|Germany|Hungary|Mexico|Netherlands|Poland|Romania|Russian Federation|Ukraine|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Italy|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Belgium|Canada|Denmark|France|Germany|Romania|United Kingdom 1
United States|Belgium|Canada|Denmark|France|Netherlands|Puerto Rico|Sweden|United Kingdom 1
United States|Belgium|Canada|Finland|Former Serbia and Montenegro|France|Germany|Netherlands|Romania|Russian Federation|United Kingdom 1
United States|Belgium|Canada|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Belgium|Canada|France|Israel|Italy|Spain|United Kingdom 1
United States|Belgium|Canada|France|Spain|United Kingdom 1
United States|Belgium|Canada|Hungary|Israel|Poland|Russian Federation 1
United States|Belgium|Canada|Italy|Netherlands|Puerto Rico|Russian Federation|Spain 1
United States|Belgium|Czech Republic|Hungary|Italy|Netherlands|Poland|Russian Federation 1
United States|Belgium|Denmark|Finland|Germany 1
United States|Belgium|Denmark|Hungary|United Kingdom 1
United States|Belgium|Italy|Spain 1
United States|Belgium|Russian Federation|United Kingdom 1
United States|Brazil|Canada|Chile|Croatia|France|Peru|Romania|Russian Federation 1
United States|Canada|China|Israel 1
United States|Canada|Czech Republic|Hungary|Romania 1
United States|Canada|Czechia|Finland|France|Germany|Greece|Poland|Russian Federation|Slovakia|South Africa|United Kingdom 1
United States|Canada|Denmark|Norway|Portugal|Spain|Sweden|United Kingdom 1
United States|Canada|Finland|Hungary|Mexico|Poland 1
United States|Canada|France|Netherlands|United Kingdom 1
United States|Canada|France|United Kingdom 1
United States|Canada|Germany 1
United States|Canada|Germany|Netherlands|Spain 1
United States|Canada|Germany|Spain|Switzerland|United Kingdom 1
United States|Canada|Hong Kong|Israel|Singapore|Switzerland 1
United States|Canada|Moldova, Republic of|Netherlands|United Kingdom 1
United States|Canada|Netherlands|United Kingdom 1
United States|Canada|Sweden 1
United States|Canada|United Kingdom 1
United States|Czechia|France|Greece|Italy|Netherlands|Romania|Spain|United Kingdom 1
United States|Czechia|Korea, Republic of|Lithuania|Slovakia 1
United States|Estonia|Latvia 1
United States|Finland|Israel|Italy|Norway|Spain|Sweden 1
United States|Finland|Sweden|United Kingdom 1
United States|France 1
United States|France|Germany|Greece|Netherlands|Spain|United Kingdom 1
United States|France|Germany|Spain 1
United States|France|Italy 1
United States|France|United Kingdom 1
United States|Germany|Italy 1
United States|Germany|Poland|Spain 1
United States|Germany|United Kingdom 1
United States|Greece|Switzerland|United Kingdom 1
United States|Hong Kong|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Hungary|Poland|Puerto Rico|Romania|Russian Federation 1
United States|Ireland 1
United States|Italy|Russian Federation|Spain 1
United States|Italy|United Kingdom 1
United States|Moldova, Republic of|South Africa 1
United States|Netherlands 1
United States|Portugal 1
United States|Russian Federation 1
United States|Singapore 1
United States|Spain|Argentina|Australia|Austria|Belgium|Canada|Chile|France|Germany|Italy|Netherlands|Poland|South Africa|United Kingdom 1
United States|Switzerland|United Kingdom 1
Venezuela 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 1542
2 214
3 143
4 90
5 66
6 51
7 41
8 48
9 21
10 24
11 30
12 20
13 19
14 13
15 10
16 28
17 17
18 10
19 13
20 6
21 10
22 6
23 11
24 6
25 7
26 4
27 7
28 8
29 8
30 5
31 5
32 4
34 4
35 4
36 5
37 2
38 2
39 2
40 1
41 3
43 3
44 1
45 3
46 1
47 4
48 1
49 1
50 4
51 1
52 2
54 3
55 4
56 2
57 1
58 2
59 3
60 2
61 2
62 2
63 1
64 2
65 1
66 2
68 1
69 3
70 2
71 3
72 1
73 1
74 2
76 2
77 1
78 2
79 1
80 2
82 2
84 1
85 2
86 1
87 1
88 2
89 1
90 1
91 1
94 1
95 1
97 1
98 1
109 1
114 1
118 1
120 1
122 1
123 1
126 1
128 1
130 1
133 1
134 1
135 2
140 3
147 4
149 2
155 1
158 1
159 1
162 1
164 1
165 1
167 1
168 1
170 3
172 3
173 1
176 1
180 1
182 1
184 1
186 2
191 1
192 1
198 1
199 2
203 1
205 2
208 1
209 1
210 1
211 1
215 2
220 1
221 1
226 1
228 1
229 1
233 1
234 2
239 1
240 1
241 2
245 1
249 1
250 1
253 1
254 1
257 1
258 1
261 1
264 1
269 1
273 1
283 1
296 1
299 1
340 1
343 1
364 1
391 1
398 1
405 1
460 1
472 1
508 1
518 1
539 1
554 1
560 1
672 1
873 1
932 1
1329 1

Phase

Phase Study_Count
Phase 2 910
N/A 738
Phase 1 374
Phase 3 325
Phase 1/Phase 2 213
Phase 4 67
Phase 2/Phase 3 36
Early Phase 1 32

Number of Arms

Number_of_Arms Count_of_Studies
1 1132
2 946
3 162
4 82
5 18
6 21
7 7
8 7
9 2
10 1
11 1
12 1
18 1
37 1
NA 313

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.00000 2.00 1.00000 8.00000 1.0000 36.0 3.0000 10.0000
1st Qu. 15.00000 30.00 17.00000 25.00000 30.0000 83.0 188.0000 42.2500
Median 28.00000 69.00 27.00000 43.50000 50.0000 137.0 398.5000 94.5000
Mean 35.15625 615.10 42.85112 68.98095 204.5913 540.8 800.5981 156.1818
3rd Qu. 50.00000 205.25 43.00000 80.00000 100.0000 291.5 984.0000 204.5000
Max. 146.00000 100000.00 1200.00000 1084.00000 99999.0000 12200.0 35533.0000 1618.0000

Trial Group Type

group_type Group_Count
Experimental 3058
Active Comparator 657
NA 313
Other 211
Placebo Comparator 192
No Intervention 135
Sham Comparator 12

Intervention Model

intervention_model Study_Count
Single Group Assignment 1340
Parallel Assignment 1051
NA 134
Sequential Assignment 80
Crossover Assignment 58
Factorial Assignment 32

Primary Purpose

primary_purpose Study_Count
Treatment 1920
Diagnostic 320
Supportive Care 166
Prevention 104
Other 66
Screening 32
Basic Science 31
NA 28
Health Services Research 22
Device Feasibility 4
Educational/Counseling/Training 2

Observational Studies

Studies by Country

Country Study_Count
United States 197
Canada 39
NA 33
France 22
United Kingdom 20
Germany 12
Spain 11
Italy 10
China 9
Korea, Republic of 8
Netherlands 8
Taiwan 8
Japan 7
Norway 7
Switzerland 7
Denmark 6
Hong Kong 6
Sweden 5
Belgium 3
Brazil 3
Hungary 3
Ireland 3
Israel 3
Russian Federation 3
United States|Canada 3
Australia 2
Austria 2
Algeria|Argentina|Australia|Austria|Brazil|Canada|Colombia|Egypt|France|Germany|Indonesia|Israel|Italy|Korea, Republic of|Lebanon|Mexico|Netherlands|New Zealand|Oman|Peru|Philippines|Saudi Arabia|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Australia|Belgium|Denmark|France|Germany|Italy|Netherlands|Norway|Romania|Turkey|United Kingdom 1
Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Netherlands|Portugal|Slovenia|Spain|United Kingdom 1
Austria|Belgium|France|Germany|Greece|Italy|Netherlands|Poland|Romania 1
Austria|Denmark|Germany 1
Belgium|Czech Republic|Germany|Hungary|United Kingdom 1
Belgium|Denmark|Finland|France|Germany|Greece|Hungary|Ireland|Italy|Netherlands|Norway|Portugal|Slovakia|Switzerland|United Kingdom 1
Belgium|Luxembourg 1
Croatia 1
Czech Republic 1
Denmark|France|Latvia|Lithuania|Netherlands|Romania|United Kingdom 1
Finland 1
Finland|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
France|Denmark|United Kingdom 1
France|Guadeloupe 1
France|United States|Argentina|Canada|Chile|Finland|Germany|Greece|Netherlands|Spain|Sweden|United Kingdom 1
Germany|Austria|Belgium|France|Israel|Luxembourg|Poland|Portugal|Russian Federation|Slovenia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Ghana 1
Greece 1
India 1
Kazakhstan 1
Mexico 1
Poland|Ukraine 1
Portugal|Spain 1
Romania 1
Turkey 1
United States|Argentina|Australia|Brazil|Canada|France|Israel|Korea, Republic of|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Austria|Belgium|Canada|Colombia|Czechia|Denmark|France|Germany|Greece|Israel|Italy|Luxembourg|Mexico|Netherlands|Portugal|Spain|Sweden|United Kingdom 1
United States|Finland 1
United States|Italy|Norway 1
United States|Mexico|Saudi Arabia 1
United States|Puerto Rico 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 331
2 25
3 22
4 8
5 8
7 7
8 4
9 4
10 6
11 1
12 1
13 2
14 2
15 2
17 1
18 2
20 3
23 4
24 1
25 1
26 2
27 1
31 1
32 3
33 2
34 1
35 1
36 2
40 1
41 1
44 1
47 2
49 1
50 1
52 1
63 1
72 1
93 1
118 1
135 1
143 2
147 1
148 1
160 1
161 1
182 1
216 1
231 1
267 1
333 1
453 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 60.000
Median 199.000
Mean 1198.204
3rd Qu 627.250
Max 96000.000

Observation Model

observational_model Study_Count
Cohort 271
Case-Only 102
NA 30
Case-Control 28
Other 18
Case Control 12
Ecologic or Community 5
Case-Crossover 3
Defined Population, Natural History 2
Defined Population 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 342
Retrospective 80
Cross-Sectional 21
NA 19
Other 8
Longitudinal, Prospective 1
Longitudinal, Retrospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
United States 15
Netherlands 5
France 2
Japan 2
Korea, Republic of 2
Luxembourg 2
NA 2
Argentina 1
Belgium 1
China|India|Japan|Korea, Republic of|Malaysia|Singapore|Taiwan|Thailand 1
Colombia 1
Hong Kong 1
Ireland 1
Italy 1
Norway 1
Spain 1
Sweden 1
Switzerland 1
United States|Australia|Brazil|Canada|Ireland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Canada|Lithuania 1

Sites per Study

Site_count Study_Count
1 26
2 2
3 4
5 1
8 1
10 1
11 1
12 2
25 1
32 1
40 1
76 1
82 1

Enrollment Metrics

Measure Registries
Min 39.000
1st Qu 237.000
Median 693.000
Mean 2190.442
3rd Qu 2000.000
Max 15000.000

Registry Model

observational_model Study_Count
Cohort 37
Case-Control 3
Case-Only 3

Time Perspective

time_perspective Study_Count
Prospective 38
Other 4
Cross-Sectional 1

Follow-up

target_duration Study_Count
10 Years 8
3 Years 7
5 Years 7
1 Year 4
36 Months 3
1 Month 2
2 Years 2
3 Months 2
6 Months 2
11 Years 1
15 Years 1
24 Months 1
4 Months 1
7 Days 1
8 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03408964 Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT03408964 Recruiting Oncology Institute of Southern Switzerland 2020-12-31
NCT03383107 Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome https://ClinicalTrials.gov/show/NCT03383107 Recruiting Weill Medical College of Cornell University 2021-01-31
NCT03383016 Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE) https://ClinicalTrials.gov/show/NCT03383016 Recruiting CHU de Quebec-Universite Laval 2020-08-31
NCT03382522 Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma https://ClinicalTrials.gov/show/NCT03382522 Completed University Hospital, Brest 2018-03-30
NCT03381326 CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. https://ClinicalTrials.gov/show/NCT03381326 Active, not recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2019-10-31
NCT03381105 From PSA to Stockholm3: Study Part 1 https://ClinicalTrials.gov/show/NCT03381105 Active, not recruiting Helse Stavanger HF 2020-12-31
NCT03376360 Functional Medical Imaging Quantization in Prostate Cancer https://ClinicalTrials.gov/show/NCT03376360 Completed University Hospital, Brest 2017-05-01
NCT03368989 The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions. https://ClinicalTrials.gov/show/NCT03368989 Completed The University of Texas Health Science Center, Houston 2017-02-07
NCT03331068 French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. https://ClinicalTrials.gov/show/NCT03331068 Completed Institut Paoli-Calmettes 2017-11-01
NCT03328364 A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden https://ClinicalTrials.gov/show/NCT03328364 Completed Astellas Pharma Inc 2017-12-24
NCT03247010 Bone Marrow Suppression and Recovery During Radionuclide Treatment https://ClinicalTrials.gov/show/NCT03247010 Active, not recruiting Rigshospitalet, Denmark 2019-10-01
NCT03236688 Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP) https://ClinicalTrials.gov/show/NCT03236688 Active, not recruiting Exosome Diagnostics, Inc. 2020-02-29
NCT03237026 Decipher the Biology of Lethal Prostate Cancer—Urine Metabolomics Profiles for Predictive/Prognostic Markers in Prostate Cancer https://ClinicalTrials.gov/show/NCT03237026 Recruiting National Taiwan University Hospital 2021-07-31
NCT03228810 Genetic Biomarker Discovery for Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT03228810 Completed Mayo Clinic 2019-04-09
NCT03213951 Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions https://ClinicalTrials.gov/show/NCT03213951 Completed Indiana University 2019-11-13
NCT03214315 Structural Network on Prostate Cancer in the French Greater West Region https://ClinicalTrials.gov/show/NCT03214315 Completed University Hospital, Tours 2016-09-27
NCT03209492 Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for “Prostate Cancer” https://ClinicalTrials.gov/show/NCT03209492 Completed Takeda 2017-12-01
NCT03194516 Ketogenic Diet and Prostate Cancer Surveillance Pilot https://ClinicalTrials.gov/show/NCT03194516 Active, not recruiting University of Maryland, Baltimore 2019-11-01
NCT03193645 Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix https://ClinicalTrials.gov/show/NCT03193645 Completed Ferring Pharmaceuticals 2018-06-30
NCT03193060 A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer https://ClinicalTrials.gov/show/NCT03193060 Completed AstraZeneca 2019-12-27
NCT03176381 Tissue Predictors of Abiraterone Benefit https://ClinicalTrials.gov/show/NCT03176381 Recruiting Tianjin Medical University Second Hospital 2019-05-05
NCT03177759 Living With Prostate Cancer (LPC) https://ClinicalTrials.gov/show/NCT03177759 Completed Vancouver Prostate Centre 2019-06-30
NCT03177551 Predictive Nomogram of CRPC https://ClinicalTrials.gov/show/NCT03177551 Recruiting Tianjin Medical University Second Hospital 2019-09-30
NCT03162003 Irish Programme for Stratified Prostate Cancer Therapy https://ClinicalTrials.gov/show/NCT03162003 Active, not recruiting Cancer Trials Ireland 2024-02-29
NCT03158922 The BARCODE 1 Study https://ClinicalTrials.gov/show/NCT03158922 Active, not recruiting Institute of Cancer Research, United Kingdom 2018-04-14
NCT03159676 Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT03159676 Active, not recruiting Mayo Clinic 2021-06-30
NCT03151356 Prostate Health Index for Prostate Cancer Diagnosis https://ClinicalTrials.gov/show/NCT03151356 Completed Hospices Civils de Lyon 2018-09-19
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT03128710 Prostate Cancer Survey https://ClinicalTrials.gov/show/NCT03128710 Active, not recruiting University of Maryland, Baltimore 2020-12-31
NCT03122743 Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03122743 Active, not recruiting Wake Forest University Health Sciences 2020-10-31
NCT03091231 Multiparametric Ultrasound-Study for the Detection of Prostate Cancer https://ClinicalTrials.gov/show/NCT03091231 Completed Martini-Klinik am UKE GmbH 2017-12-31
NCT03082274 Prospective Validation of Prostate Biomarkers for Repeat Biopsy https://ClinicalTrials.gov/show/NCT03082274 Enrolling by invitation MDx Health 2019-12-30
NCT03034187 Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate https://ClinicalTrials.gov/show/NCT03034187 Recruiting University Medical Center Groningen 2025-01-31
NCT03031418 Clinical Evaluation of the ‘ExoDx Prostate IntelliScore’ (EPI) https://ClinicalTrials.gov/show/NCT03031418 Recruiting Exosome Diagnostics, Inc. 2020-02-01
NCT03017794 Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma https://ClinicalTrials.gov/show/NCT03017794 Recruiting Mayo Clinic 2020-12-31
NCT03017313 To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT03017313 Active, not recruiting Ipsen 2019-12-11
NCT03009123 Will Erectile Dysfunction Increase the Risk of Prostate Cancer https://ClinicalTrials.gov/show/NCT03009123 Completed Kuang Tien General Hospital 2017-03-15
NCT02997709 Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients https://ClinicalTrials.gov/show/NCT02997709 Recruiting University of Miami 2023-06-30
NCT02998619 Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis https://ClinicalTrials.gov/show/NCT02998619 Completed Kantonsspital Graubuenden 2017-11-11
NCT02991794 Prostatectomies Using Einstein Vision® 3D https://ClinicalTrials.gov/show/NCT02991794 Active, not recruiting Aesculap AG 2019-12-31
NCT02974231 Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT02974231 Completed Institut de Cancérologie de Lorraine 2015-03-31
NCT02963675 Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden https://ClinicalTrials.gov/show/NCT02963675 Completed Bayer 2017-03-31
NCT02941029 RADTOX: Measuring Radiation Toxicity Using Circulating DNA https://ClinicalTrials.gov/show/NCT02941029 Completed University of Florida 2017-03-31
NCT02940977 Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique https://ClinicalTrials.gov/show/NCT02940977 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2019-03-30
NCT02925702 PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. https://ClinicalTrials.gov/show/NCT02925702 Active, not recruiting Centro Nacional de Investigaciones Oncologicas CARLOS III 2019-01-31
NCT02922218 PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. https://ClinicalTrials.gov/show/NCT02922218 Active, not recruiting Centro Nacional de Investigaciones Oncologicas CARLOS III 2020-01-31
NCT02919904 Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT https://ClinicalTrials.gov/show/NCT02919904 Completed Vancouver Prostate Centre 2018-09-30
NCT02899312 PSMA PET/CT for Assessment of Recurrent Prostate Cancer https://ClinicalTrials.gov/show/NCT02899312 Recruiting British Columbia Cancer Agency 2021-09-30
NCT02899104 Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer ) https://ClinicalTrials.gov/show/NCT02899104 Completed Bayer 2019-03-31
NCT02882178 Formal Consensus Method to Evaluate the Conformity of Prescription of a Recently Approved Chemotherapy Treatment in an Observatory Study https://ClinicalTrials.gov/show/NCT02882178 Completed Institut Bergonié 2015-04-30
NCT02886598 Safety and Efficacy of Firmagon® (Degarelix) for Injection https://ClinicalTrials.gov/show/NCT02886598 Completed Ferring Pharmaceuticals 2019-03-26
NCT02873117 Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers https://ClinicalTrials.gov/show/NCT02873117 Completed Rennes University Hospital 2016-12-31
NCT02873013 Asia Study Group of Prostate Cancer (A-CaP Study) https://ClinicalTrials.gov/show/NCT02873013 Enrolling by invitation Japan Study Group of Prostate Cancer 2019-03-31
NCT02856100 Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02856100 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2019-01-31
NCT02854982 Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer https://ClinicalTrials.gov/show/NCT02854982 Completed Centre Hospitalier Universitaire de Nīmes 2018-01-01
NCT02853097 Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT02853097 Recruiting University of Southern California 2020-06-14
NCT02853409 Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT02853409 Completed Ipsen 2015-12-31
NCT02825875 Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT02825875 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2020-04-30
NCT02813408 A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants https://ClinicalTrials.gov/show/NCT02813408 Completed Janssen Pharmaceutica N.V., Belgium 2018-03-21
NCT02816983 SBRT for Oligometastatic Castration-Refractory Prostate Cancer https://ClinicalTrials.gov/show/NCT02816983 Active, not recruiting Mayo Clinic 2020-08-31
NCT02803086 Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer https://ClinicalTrials.gov/show/NCT02803086 Recruiting IRCCS San Raffaele 2020-12-31
NCT02793882 Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer https://ClinicalTrials.gov/show/NCT02793882 Completed Sir Mortimer B. Davis - Jewish General Hospital 2017-03-25
NCT02788409 Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US https://ClinicalTrials.gov/show/NCT02788409 Completed Bayer 2018-05-09
NCT02787837 PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. https://ClinicalTrials.gov/show/NCT02787837 Active, not recruiting Centro Nacional de Investigaciones Oncologicas CARLOS III 2018-04-30
NCT02761135 Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique? https://ClinicalTrials.gov/show/NCT02761135 Completed Kronoberg County Council 2018-03-31
NCT02729103 Treatment Patterns in Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT02729103 Completed Bayer 2017-01-19
NCT02723734 Validation Study on the Impact of Decipher® Testing - VANDAAM Study https://ClinicalTrials.gov/show/NCT02723734 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2021-04-30
NCT02705846 Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations https://ClinicalTrials.gov/show/NCT02705846 Recruiting Institute of Cancer Research, United Kingdom 2020-12-31
NCT02702908 Second Primary Cancers in Patients With Castration Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02702908 Completed Bayer 2017-10-20
NCT02702856 Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer https://ClinicalTrials.gov/show/NCT02702856 Completed Exosome Diagnostics, Inc. 2015-04-30
NCT02689271 CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr https://ClinicalTrials.gov/show/NCT02689271 Completed University College, London 2019-12-31
NCT02677376 Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC https://ClinicalTrials.gov/show/NCT02677376 Completed University of Wisconsin, Madison 2018-03-30
NCT02669771 Long-Term Specified Drug Use-Results Survey for Xtandi Capsule https://ClinicalTrials.gov/show/NCT02669771 Completed Astellas Pharma Inc 2018-11-30
NCT02669147 A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC https://ClinicalTrials.gov/show/NCT02669147 Active, not recruiting Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2021-03-31
NCT02663193 Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability https://ClinicalTrials.gov/show/NCT02663193 Completed Janssen Scientific Affairs, LLC 2017-01-31
NCT02657863 Cancer DNA Detection in Blood and Urine https://ClinicalTrials.gov/show/NCT02657863 Active, not recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2020-11-30
NCT02652000 Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy https://ClinicalTrials.gov/show/NCT02652000 Completed Kantonsspital Graubuenden 2016-12-31
NCT02630641 Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone. https://ClinicalTrials.gov/show/NCT02630641 Completed Ipsen 2017-11-30
NCT02608359 A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02608359 Recruiting Johnson & Johnson Private Limited 2021-11-30
NCT02573636 The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy https://ClinicalTrials.gov/show/NCT02573636 Recruiting Sir Mortimer B. Davis - Jewish General Hospital 2022-01-31
NCT02981797 Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 https://ClinicalTrials.gov/show/NCT02981797 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2017-08-29
NCT02380274 Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) https://ClinicalTrials.gov/show/NCT02380274 Active, not recruiting Astellas Pharma Inc 2021-04-30
NCT02564120 North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) https://ClinicalTrials.gov/show/NCT02564120 Completed UNC Lineberger Comprehensive Cancer Center 2018-12-31
NCT02562131 PET-MR-PSA Prostate Cancer Recidive Study https://ClinicalTrials.gov/show/NCT02562131 Active, not recruiting Norwegian University of Science and Technology 2027-12-31
NCT00342771 An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males https://ClinicalTrials.gov/show/NCT00342771 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02543905 The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment https://ClinicalTrials.gov/show/NCT02543905 Recruiting Institute of Cancer Research, United Kingdom 2021-02-28
NCT02542501 Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues https://ClinicalTrials.gov/show/NCT02542501 Completed Ipsen 2018-07-21
NCT02526797 Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance https://ClinicalTrials.gov/show/NCT02526797 Enrolling by invitation Herlev Hospital 2020-07-31
NCT02526589 Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy https://ClinicalTrials.gov/show/NCT02526589 Completed Tampere University Hospital 2017-09-20
NCT02518698 Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population https://ClinicalTrials.gov/show/NCT02518698 Completed Bayer 2017-09-30
NCT02512185 Towards Optimal Prescription of Chemotherapy in Prostate Cancer https://ClinicalTrials.gov/show/NCT02512185 Recruiting University Health Network, Toronto 2019-12-31
NCT02495974 European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) https://ClinicalTrials.gov/show/NCT02495974 Completed Astellas Pharma Inc 2019-02-08
NCT02471469 Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response https://ClinicalTrials.gov/show/NCT02471469 Completed Radboud University 2019-02-13
NCT02462447 Carbon-11 Labeled Sarcosine in Prostate Cancer https://ClinicalTrials.gov/show/NCT02462447 Completed University of Michigan 2017-02-08
NCT02456571 CTC Immune Checkpoint https://ClinicalTrials.gov/show/NCT02456571 Completed Duke University 2019-06-13
NCT02450812 Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany https://ClinicalTrials.gov/show/NCT02450812 Active, not recruiting Bayer 2020-06-01
NCT02443571 Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC) https://ClinicalTrials.gov/show/NCT02443571 Completed Blue Earth Diagnostics 2015-06-30
NCT03386812 Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT03386812 Active, not recruiting University of Texas Southwestern Medical Center 2020-10-01
NCT02432001 Radiologically Guided Biopsies of mCRPC https://ClinicalTrials.gov/show/NCT02432001 Active, not recruiting University of California, San Francisco 2020-01-01
NCT02426333 Optimizing Abiraterone Therapy https://ClinicalTrials.gov/show/NCT02426333 Completed Radboud University 2019-04-24
NCT02425800 Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells https://ClinicalTrials.gov/show/NCT02425800 Completed Wake Forest University Health Sciences 2018-11-05
NCT02424448 Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02424448 Completed The Christie NHS Foundation Trust 2016-07-31
NCT02425592 Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) https://ClinicalTrials.gov/show/NCT02425592 Recruiting Yale University 2020-05-31
NCT02414971 Relationship of Mitochondrial Enzymes With Cancer Related Fatigue https://ClinicalTrials.gov/show/NCT02414971 Completed University of Florida 2019-01-14
NCT02410044 Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer https://ClinicalTrials.gov/show/NCT02410044 Active, not recruiting iOMEDICO AG 2019-08-16
NCT02397629 Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis https://ClinicalTrials.gov/show/NCT02397629 Completed Wake Forest University Health Sciences 2016-05-31
NCT02398526 Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases https://ClinicalTrials.gov/show/NCT02398526 Active, not recruiting Bayer 2020-05-20
NCT02394223 FFOCT for the Diagnosis of Prostate Cancer https://ClinicalTrials.gov/show/NCT02394223 Completed Assistance Publique - Hôpitaux de Paris 2017-01-27
NCT02388308 Evaluation of Clarity Ultrasound Guidance for Prostate Therapy https://ClinicalTrials.gov/show/NCT02388308 Completed Institute of Cancer Research, United Kingdom 2018-06-18
NCT02366494 Micro RNAs to Predict Response to Androgen Deprivation Therapy https://ClinicalTrials.gov/show/NCT02366494 Recruiting Medical College of Wisconsin 2021-02-28
NCT02365883 Transrectal Photoacoustic Imaging of the Prostate https://ClinicalTrials.gov/show/NCT02365883 Active, not recruiting Stanford University 2016-12-20
NCT02362620 PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. https://ClinicalTrials.gov/show/NCT02362620 Active, not recruiting Centro Nacional de Investigaciones Oncologicas CARLOS III 2018-04-30
NCT02364531 A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting https://ClinicalTrials.gov/show/NCT02364531 Completed Janssen Inc. 2018-11-01
NCT02353715 Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing https://ClinicalTrials.gov/show/NCT02353715 Completed Duke University 2018-11-14
NCT02313623 MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research https://ClinicalTrials.gov/show/NCT02313623 Recruiting Yale University 2022-10-31
NCT02274350 The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects https://ClinicalTrials.gov/show/NCT02274350 Completed Herlev Hospital 2015-10-31
NCT02264379 Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma https://ClinicalTrials.gov/show/NCT02264379 Active, not recruiting Technische Universität Dresden 2020-10-31
NCT02243033 Phase II Laser Focal Therapy of Prostate Cancer https://ClinicalTrials.gov/show/NCT02243033 Recruiting Desert Medical Imaging 2036-05-31
NCT02236637 A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care https://ClinicalTrials.gov/show/NCT02236637 Completed Janssen Pharmaceutica N.V., Belgium 2018-11-21
NCT02238366 Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer https://ClinicalTrials.gov/show/NCT02238366 Completed Ipsen 2019-06-06
NCT02234089 Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. https://ClinicalTrials.gov/show/NCT02234089 Completed Ferring Pharmaceuticals 2019-06-30
NCT02230059 Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) https://ClinicalTrials.gov/show/NCT02230059 Completed Janssen Research & Development, LLC 2014-05-31
NCT02237170 Immune Monitoring on Sipuleucel-T https://ClinicalTrials.gov/show/NCT02237170 Completed Icahn School of Medicine at Mount Sinai 2016-12-31
NCT02232230 A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T https://ClinicalTrials.gov/show/NCT02232230 Completed 21st Century Oncology 2018-06-05
NCT02229253 Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT02229253 Completed Ferring Pharmaceuticals 2017-10-04
NCT02228265 Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide https://ClinicalTrials.gov/show/NCT02228265 Active, not recruiting OHSU Knight Cancer Institute 2019-10-01
NCT02224911 Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT02224911 Completed Jonsson Comprehensive Cancer Center 2019-10-21
NCT02189486 Prostate Cancer Upgrading Reference Set https://ClinicalTrials.gov/show/NCT02189486 Recruiting The University of Texas Health Science Center at San Antonio 2021-03-31
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. https://ClinicalTrials.gov/show/NCT02186925 Recruiting Meir Medical Center 2019-08-31
NCT02186444 Navigator Guided e-Psychoeducational Intervention https://ClinicalTrials.gov/show/NCT02186444 Completed H. Lee Moffitt Cancer Center and Research Institute 2016-12-30
NCT01325506 Effectiveness of Open and Robotic Prostatectomy https://ClinicalTrials.gov/show/NCT01325506 Active, not recruiting Dana-Farber Cancer Institute 2024-02-29
NCT02167893 Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey “Long-term Use Survey in Prostate Cancer Patients (96 Weeks)” https://ClinicalTrials.gov/show/NCT02167893 Completed Takeda 2010-12-31
NCT02155998 Non-Interventional Study PREVENT https://ClinicalTrials.gov/show/NCT02155998 Completed AstraZeneca 2016-12-14
NCT02151097 PRIME - PRostate Imaging for Margin Evaluation https://ClinicalTrials.gov/show/NCT02151097 Completed Lightpoint Medical Limited 2016-06-30
NCT02141438 Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02141438 Active, not recruiting Bayer 2024-12-31
NCT02135653 A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer https://ClinicalTrials.gov/show/NCT02135653 Completed Abramson Cancer Center of the University of Pennsylvania 2018-05-24
NCT02128334 An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation https://ClinicalTrials.gov/show/NCT02128334 Completed Astellas Pharma Inc 2016-03-31
NCT02110667 Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy https://ClinicalTrials.gov/show/NCT02110667 Completed University of Vermont Medical Center 2016-01-31
NCT02111954 Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT02111954 Completed University of Lausanne Hospitals 2016-10-28
NCT02088164 Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men https://ClinicalTrials.gov/show/NCT02088164 Completed National Taiwan University Hospital 2012-04-30
NCT02070575 Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence https://ClinicalTrials.gov/show/NCT02070575 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT02066961 A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT02066961 Completed Astellas Pharma Inc 2019-11-14
NCT01306890 A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01306890 Completed Dendreon 2017-01-17
NCT01303692 Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent https://ClinicalTrials.gov/show/NCT01303692 Completed AstraZeneca 2014-02-28
NCT01284608 Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) https://ClinicalTrials.gov/show/NCT01284608 Completed AstraZeneca 2012-12-31
NCT01277562 Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer https://ClinicalTrials.gov/show/NCT01277562 Completed City of Hope Medical Center 2012-12-31
NCT02034825 Multi-site Decision Impact Study for Decipher https://ClinicalTrials.gov/show/NCT02034825 Completed GenomeDx Biosciences Corp 2015-01-31
NCT02034812 Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists https://ClinicalTrials.gov/show/NCT02034812 Completed GenomeDx Biosciences Corp 2014-07-31
NCT02020876 Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations https://ClinicalTrials.gov/show/NCT02020876 Completed GenomeDx Biosciences Corp 2013-01-31
NCT04240327 Marker Driven Selection of Patients for Prostate Biopsy and Management https://ClinicalTrials.gov/show/NCT04240327 Recruiting University of Miami 2025-06-01
NCT03354416 Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer https://ClinicalTrials.gov/show/NCT03354416 Recruiting National Institutes of Health Clinical Center (CC) 2027-12-31
NCT02013180 Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection https://ClinicalTrials.gov/show/NCT02013180 Completed Bagcilar Training and Research Hospital 2013-01-31
NCT02008058 Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02008058 Completed UNC Lineberger Comprehensive Cancer Center 2017-03-31
NCT02003417 Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy https://ClinicalTrials.gov/show/NCT02003417 Completed UNC Lineberger Comprehensive Cancer Center 2016-07-31
NCT02001597 Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy https://ClinicalTrials.gov/show/NCT02001597 Completed University of British Columbia 2013-11-30
NCT01968538 Metabolomic Study for Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT01968538 Enrolling by invitation Georgetown University 2022-12-31
NCT01961713 Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy https://ClinicalTrials.gov/show/NCT01961713 Recruiting Massachusetts General Hospital 2020-04-30
NCT01960881 Evaluation of Diet and Exercise in Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT01960881 Active, not recruiting AbbVie 2021-07-30
NCT01953640 Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy https://ClinicalTrials.gov/show/NCT01953640 Active, not recruiting Mayo Clinic 2015-12-03
NCT01943500 Collection of Blood Specimens for Circulating Tumor Cell Analysis https://ClinicalTrials.gov/show/NCT01943500 Completed Viatar LLC 2014-01-28
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01915316 Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy https://ClinicalTrials.gov/show/NCT01915316 Completed ProSight 2014-12-31
NCT01905488 Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy https://ClinicalTrials.gov/show/NCT01905488 Completed Yonsei University 2009-11-30
NCT01877070 Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies https://ClinicalTrials.gov/show/NCT01877070 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT01857908 A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone https://ClinicalTrials.gov/show/NCT01857908 Completed University Health Network, Toronto 2014-11-30
NCT01834001 Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy https://ClinicalTrials.gov/show/NCT01834001 Recruiting National Institutes of Health Clinical Center (CC) 2025-02-25
NCT01813097 Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer https://ClinicalTrials.gov/show/NCT01813097 Completed Chinese PLA General Hospital 2013-03-31
NCT01810627 Application of Megavoltage Imaging to Reduce Artifact After Seed Implants https://ClinicalTrials.gov/show/NCT01810627 Completed University of Kentucky 2016-04-30
NCT01793077 Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT01793077 Completed Astellas Pharma Inc 2013-12-31
NCT01780701 Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT01780701 Completed OHSU Knight Cancer Institute 2016-01-31
NCT01767363 WEUSKOP5723: Prostate Cancer Study https://ClinicalTrials.gov/show/NCT01767363 Completed GlaxoSmithKline 2016-03-31
NCT01766492 Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery https://ClinicalTrials.gov/show/NCT01766492 Recruiting Georgetown University 2020-04-30
NCT01742962 Prevalence of Neglected Side Effects to Radical Prostatectomy https://ClinicalTrials.gov/show/NCT01742962 Completed Copenhagen University Hospital at Herlev 2013-07-31
NCT01737242 UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies https://ClinicalTrials.gov/show/NCT01737242 Recruiting Institute of Cancer Research, United Kingdom 2022-12-31
NCT01729676 Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation https://ClinicalTrials.gov/show/NCT01729676 Completed Ferring Pharmaceuticals 2014-05-31
NCT01710098 Treatment of Prostate Cancer With Firmagon® https://ClinicalTrials.gov/show/NCT01710098 Completed United Clinic Management GmbH 2014-06-30
NCT01673581 Shared Decision Making in Low Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT01673581 Active, not recruiting Massachusetts General Hospital 2015-12-31
NCT01672905 PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 https://ClinicalTrials.gov/show/NCT01672905 Completed Eastern Cooperative Oncology Group 2013-01-07
NCT01672411 Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer https://ClinicalTrials.gov/show/NCT01672411 Completed University Of Perugia 2012-12-31
NCT01640262 Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup https://ClinicalTrials.gov/show/NCT01640262 Completed Copenhagen University Hospital at Herlev 2014-08-31
NCT01621425 Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity https://ClinicalTrials.gov/show/NCT01621425 Completed Radboud University 2015-05-31
NCT01614548 Management of Prostate Cancer in Central China https://ClinicalTrials.gov/show/NCT01614548 Completed Zhengzhou University 2011-12-31
NCT01599182 Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT01599182 Completed University of Waterloo 2014-12-31
NCT01594502 Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies https://ClinicalTrials.gov/show/NCT01594502 Active, not recruiting University of Illinois at Chicago 2019-11-30
NCT01577836 Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy https://ClinicalTrials.gov/show/NCT01577836 Active, not recruiting Centre Hospitalier Universitaire de Nīmes 2019-09-30
NCT01574846 Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01574846 Completed Orion Corporation, Orion Pharma 2014-04-30
NCT01560858 Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State https://ClinicalTrials.gov/show/NCT01560858 Completed Ipsen 2013-05-31
NCT01535898 Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers https://ClinicalTrials.gov/show/NCT01535898 Completed Memorial Sloan Kettering Cancer Center 2015-02-28
NCT01529086 For Cause Prostate Biopsy in REDUCE Population Trial https://ClinicalTrials.gov/show/NCT01529086 Completed The Cleveland Clinic 2012-02-29
NCT01545154 The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer https://ClinicalTrials.gov/show/NCT01545154 Completed University of Vermont Medical Center 2013-10-31
NCT01525914 Response of Patients on Surveillance for Prostate Cancer to Dutasteride https://ClinicalTrials.gov/show/NCT01525914 Completed Sunnybrook Health Sciences Centre 2010-08-31
NCT01516866 Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy https://ClinicalTrials.gov/show/NCT01516866 Completed University of Wisconsin, Madison 2015-09-30
NCT01514669 Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer https://ClinicalTrials.gov/show/NCT01514669 Active, not recruiting University of Arkansas 2021-02-28
NCT01501630 Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer https://ClinicalTrials.gov/show/NCT01501630 Completed Assistance Publique - Hôpitaux de Paris 2014-12-31
NCT01499381 EMBRACE1: Prostate Biorepository https://ClinicalTrials.gov/show/NCT01499381 Completed Caris Science, Inc. 2012-07-31
NCT01492751 Effectiveness of Localized Prostate Cancer Treatments https://ClinicalTrials.gov/show/NCT01492751 Active, not recruiting Fundacion IMIM 2015-05-31
NCT03914391 To Identify Potential New Urine Markers for the Screening of Prostate Cancer https://ClinicalTrials.gov/show/NCT03914391 Recruiting Chinese University of Hong Kong 2023-12-31
NCT01464216 MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness https://ClinicalTrials.gov/show/NCT01464216 Recruiting Oslo University Hospital 2016-12-31
NCT01447186 Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men https://ClinicalTrials.gov/show/NCT01447186 Completed M.D. Anderson Cancer Center 2015-01-13
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia https://ClinicalTrials.gov/show/NCT01444456 Completed Amgen 2013-08-31
NCT01441713 Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01441713 Completed Copenhagen University Hospital at Herlev 2012-05-31
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) https://ClinicalTrials.gov/show/NCT01418040 Completed Calvary Mater Newcastle, Australia 2017-07-20
NCT01401972 Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients https://ClinicalTrials.gov/show/NCT01401972 Completed Sunnybrook Health Sciences Centre 2018-09-30
NCT01386684 Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study https://ClinicalTrials.gov/show/NCT01386684 Completed AbbVie 2016-09-08
NCT01379872 Assessment of New Radiation Oncology Technologies and Treatments https://ClinicalTrials.gov/show/NCT01379872 Completed Trans-Tasman Radiation Oncology Group (TROG) 2012-05-31
NCT01383863 A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01383863 Completed Ipsen 2014-05-31
NCT01376674 T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer https://ClinicalTrials.gov/show/NCT01376674 Completed University Hospital Tuebingen NA
NCT01371513 Korean Practice Patterns for Screening PCA(Prostate Cancer) https://ClinicalTrials.gov/show/NCT01371513 Completed GlaxoSmithKline 2011-06-30
NCT01366053 Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists https://ClinicalTrials.gov/show/NCT01366053 Completed CMX Research 2015-07-31
NCT01347476 Aggressive Prostate Cancers in Elderly Patients https://ClinicalTrials.gov/show/NCT01347476 Completed Seoul National University Hospital 2010-10-31
NCT01337258 Economic Analyses of the REDUCE Trial https://ClinicalTrials.gov/show/NCT01337258 Completed GlaxoSmithKline 2010-07-31
NCT01320735 Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia https://ClinicalTrials.gov/show/NCT01320735 Completed AbbVie 2014-05-31
NCT04421781 Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results https://ClinicalTrials.gov/show/NCT04421781 Completed Hospices Civils de Lyon 2020-04-01
NCT04398173 Detection Rate of Prostate Cancer in Men Undergoing MRI https://ClinicalTrials.gov/show/NCT04398173 Active, not recruiting Fondazione del Piemonte per l’Oncologia 2020-10-31
NCT04357717 ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting https://ClinicalTrials.gov/show/NCT04357717 Recruiting Exosome Diagnostics, Inc. 2020-08-31
NCT04341324 Effect of ADT in Chinese Male With Prostate Cancer https://ClinicalTrials.gov/show/NCT04341324 Completed Chinese University of Hong Kong 2019-12-04
NCT04321187 Influence of Prostate Cancer Radiation on Aging https://ClinicalTrials.gov/show/NCT04321187 Recruiting Medical University of Graz 2021-08-31
NCT04298112 PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment https://ClinicalTrials.gov/show/NCT04298112 Recruiting Norwegian University of Science and Technology 2023-05-31
NCT04299997 Evaluation of the PI-RADS v2.1 Score Using Multiple Readers https://ClinicalTrials.gov/show/NCT04299997 Active, not recruiting Hospices Civils de Lyon 2020-01-31
NCT04281147 Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body https://ClinicalTrials.gov/show/NCT04281147 Recruiting Bayer 2020-10-01
NCT04268628 A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol https://ClinicalTrials.gov/show/NCT04268628 Recruiting Janssen-Cilag Farmaceutica Ltda. 2020-10-05
NCT04256993 PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn https://ClinicalTrials.gov/show/NCT04256993 Active, not recruiting Bayer 2021-06-01
NCT04254133 GIFTS Study for Prostate Cancer https://ClinicalTrials.gov/show/NCT04254133 Enrolling by invitation Fred Hutchinson Cancer Research Center 2023-08-31
NCT04251546 Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV https://ClinicalTrials.gov/show/NCT04251546 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2021-05-30
NCT04247217 Immune Profiling After HDR in Local Relapsed Prostate Cancer https://ClinicalTrials.gov/show/NCT04247217 Recruiting Maastricht Radiation Oncology 2021-01-01
NCT04219059 MR Radiomic Features in Prostate Cancer https://ClinicalTrials.gov/show/NCT04219059 Recruiting IRCCS San Raffaele 2021-09-06
NCT04193657 Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC https://ClinicalTrials.gov/show/NCT04193657 Recruiting University Health Network, Toronto 2021-09-30
NCT04191980 Deep Learning for Prostate Segmentation https://ClinicalTrials.gov/show/NCT04191980 Recruiting Hospices Civils de Lyon 2020-01-31
NCT04189770 Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners https://ClinicalTrials.gov/show/NCT04189770 Recruiting M.D. Anderson Cancer Center 2022-01-01
NCT04188275 CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION https://ClinicalTrials.gov/show/NCT04188275 Recruiting Azienda Ospedaliero-Universitaria Careggi 2020-06-30
NCT04167722 How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients https://ClinicalTrials.gov/show/NCT04167722 Recruiting Imperial College London 2021-10-01
NCT04124900 Telomere Associated Variables (TAVs) in Prostate Cancer https://ClinicalTrials.gov/show/NCT04124900 Recruiting Life Length SL 2020-11-15
NCT04117594 Whole Body Magnetic Resonance Imaging Study https://ClinicalTrials.gov/show/NCT04117594 Recruiting Royal Marsden NHS Foundation Trust 2021-06-30
NCT04110782 Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) https://ClinicalTrials.gov/show/NCT04110782 Recruiting Azienda Policlinico Umberto I 2019-06-30
NCT04081428 Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT https://ClinicalTrials.gov/show/NCT04081428 Recruiting NHS Lothian 2019-10-11
NCT04067960 Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer https://ClinicalTrials.gov/show/NCT04067960 Recruiting Mayo Clinic 2020-12-31
NCT04067713 Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT04067713 Recruiting University College, London 2022-11-28
NCT04057859 A Clinical Study in Prostate Cancer Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training https://ClinicalTrials.gov/show/NCT04057859 Active, not recruiting CMX Research 2019-11-30
NCT04043637 Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks https://ClinicalTrials.gov/show/NCT04043637 Completed Consorci Sanitari Integral 2018-12-03
NCT04030338 Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer https://ClinicalTrials.gov/show/NCT04030338 Recruiting Memorial Sloan Kettering Cancer Center 2022-07-31
NCT04021394 Influence of EMT on CTCs and Disease Progression in Prostate Cancer https://ClinicalTrials.gov/show/NCT04021394 Recruiting Lawson Health Research Institute 2020-09-30
NCT04017325 European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up https://ClinicalTrials.gov/show/NCT04017325 Active, not recruiting Steba Biotech S.A. 2020-06-30
NCT04000776 3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT04000776 Recruiting Université de Sherbrooke 2021-09-30
NCT03996993 Defining Recurrent Disease With Axuminâ„¢ https://ClinicalTrials.gov/show/NCT03996993 Recruiting Cancer Center of Irvine 2020-09-30
NCT03982706 Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy https://ClinicalTrials.gov/show/NCT03982706 Enrolling by invitation Rabin Medical Center 2020-06-06
NCT03982095 Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03982095 Recruiting Arcispedale Santa Maria Nuova-IRCCS 2020-09-30
NCT03979079 Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model https://ClinicalTrials.gov/show/NCT03979079 Completed Institut Bergonié 2018-12-31
NCT03967080 Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI https://ClinicalTrials.gov/show/NCT03967080 Recruiting East and North Hertfordshire NHS Trust 2020-03-31
NCT03970863 Focal Therapy for Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT03970863 Recruiting China Medical University Hospital 2019-11-10
NCT03963739 Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer https://ClinicalTrials.gov/show/NCT03963739 Recruiting Wake Forest University Health Sciences 2021-09-01
NCT03957252 Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer https://ClinicalTrials.gov/show/NCT03957252 Recruiting Nanostics 2021-12-31
NCT03948204 Quality of Life and Shared Decision Making in Prostate Cancer https://ClinicalTrials.gov/show/NCT03948204 Enrolling by invitation Cancer Registry of Norway 2022-03-31
NCT03927287 Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer https://ClinicalTrials.gov/show/NCT03927287 Completed Rabin Medical Center 2018-12-30
NCT03913039 Reduction of Prostate Biopsy Morbidity https://ClinicalTrials.gov/show/NCT03913039 Recruiting Maimonides Medical Center 2021-04-15
NCT03912883 Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting https://ClinicalTrials.gov/show/NCT03912883 Active, not recruiting Queen Mary University of London 2015-01-31
NCT03911999 Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients https://ClinicalTrials.gov/show/NCT03911999 Recruiting Chinese University of Hong Kong 2021-04-30
NCT03896984 Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo). https://ClinicalTrials.gov/show/NCT03896984 Active, not recruiting Bayer 2020-07-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03893929 The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population https://ClinicalTrials.gov/show/NCT03893929 Recruiting Chinese University of Hong Kong 2025-12-31
NCT03893123 Prostate Cancer Risk in Firefighters https://ClinicalTrials.gov/show/NCT03893123 Active, not recruiting Oslo University Hospital 2020-02-01
NCT03891732 MRI Prostate for Chinese Men Being Screened for Prostate Cancer https://ClinicalTrials.gov/show/NCT03891732 Recruiting Chinese University of Hong Kong 2022-01-31
NCT03888742 The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03888742 Recruiting Chinese University of Hong Kong 2021-07-31
NCT03867357 Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia https://ClinicalTrials.gov/show/NCT03867357 Recruiting Seattle Institute for Biomedical and Clinical Research 2021-08-31
NCT03857477 The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. https://ClinicalTrials.gov/show/NCT03857477 Recruiting Institute of Cancer Research, United Kingdom 2020-03-01
NCT03851211 Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation https://ClinicalTrials.gov/show/NCT03851211 Recruiting The Leeds Teaching Hospitals NHS Trust 2020-10-30
NCT03805919 Men at High Genetic Risk for Prostate Cancer https://ClinicalTrials.gov/show/NCT03805919 Recruiting National Institutes of Health Clinical Center (CC) 2029-01-01
NCT03807492 Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) https://ClinicalTrials.gov/show/NCT03807492 Recruiting Thomas Jefferson University 2024-01-19
NCT03784924 EDRN Prostate MRI Biomarker Study https://ClinicalTrials.gov/show/NCT03784924 Recruiting University of Michigan 2021-02-04
NCT03783741 The Biopsychosocial Burden of Prostate Biopsy https://ClinicalTrials.gov/show/NCT03783741 Completed University of Campinas, Brazil 2015-01-31
NCT03756077 A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer https://ClinicalTrials.gov/show/NCT03756077 Recruiting Wuhan Union Hospital, China 2019-12-31
NCT03703778 Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) https://ClinicalTrials.gov/show/NCT03703778 Recruiting Chinese University of Hong Kong 2025-10-31
NCT03707574 Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study https://ClinicalTrials.gov/show/NCT03707574 Recruiting National Cancer Institute (NCI) 2023-05-01
NCT03702439 Prostate Cancer Screening Trial Using Imaging https://ClinicalTrials.gov/show/NCT03702439 Completed Imperial College London 2019-05-15
NCT03694483 Prostasomes as Diagnostic Tool for Prostate Cancer Detection https://ClinicalTrials.gov/show/NCT03694483 Recruiting Hackensack Meridian Health 2023-10-01
NCT03692585 Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior https://ClinicalTrials.gov/show/NCT03692585 Completed Danish Cancer Society 2016-04-30
NCT03692104 US-CT Fusion for Post Implant Dosimetry https://ClinicalTrials.gov/show/NCT03692104 Completed British Columbia Cancer Agency 2018-02-28
NCT03692000 Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT03692000 Active, not recruiting Danish Cancer Society 2018-10-01
NCT03687918 External Validation of Prostate MRI QCAD/Lyon https://ClinicalTrials.gov/show/NCT03687918 Recruiting Hospices Civils de Lyon 2018-09-30
NCT03679819 Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer https://ClinicalTrials.gov/show/NCT03679819 Recruiting Institut Paoli-Calmettes 2021-04-30
NCT03677414 Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03677414 Active, not recruiting Medical University of Graz 2021-01-31
NCT03677076 Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT03677076 Recruiting Medical University of South Carolina 2020-12-29
NCT03656822 Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models https://ClinicalTrials.gov/show/NCT03656822 Completed NYU Langone Health 2019-12-31
NCT03650946 Clinical Application of 68Ga-PSMA PET in Prostate Cancer https://ClinicalTrials.gov/show/NCT03650946 Recruiting National Taiwan University Hospital 2019-07-31
NCT03630926 Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. https://ClinicalTrials.gov/show/NCT03630926 Active, not recruiting Intermountain Health Care, Inc. 2019-08-31
NCT03620786 HIFU for Focal Ablation of Prostate Tissue: An Observational Study https://ClinicalTrials.gov/show/NCT03620786 Enrolling by invitation University of California, Los Angeles 2021-12-31
NCT03615599 Plant-based Diets and Risk of Cancer in the Adventist Health Study-2 https://ClinicalTrials.gov/show/NCT03615599 Active, not recruiting Loma Linda University 2013-12-31
NCT03615131 Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer https://ClinicalTrials.gov/show/NCT03615131 Completed Kantonsspital Winterthur KSW 2017-03-30
NCT03609736 PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life https://ClinicalTrials.gov/show/NCT03609736 Recruiting Grand River Hospital 2019-08-31
NCT03611686 Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies https://ClinicalTrials.gov/show/NCT03611686 Recruiting University Hospital, Rouen 2026-04-30
NCT00836238 Questionnaire and Fall Risk Assessment https://ClinicalTrials.gov/show/NCT00836238 Completed M.D. Anderson Cancer Center 2009-06-30
NCT03601143 Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT03601143 Recruiting Technische Universität München 2021-11-01
NCT03579680 De-implementation of Low Value Castration for Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT03579680 Recruiting University of Michigan 2021-06-30
NCT03565289 PRospective Prostate biOmarker Study https://ClinicalTrials.gov/show/NCT03565289 Active, not recruiting ProteoMediX AG 2019-12-31
NCT03563014 A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223 https://ClinicalTrials.gov/show/NCT03563014 Completed Bayer 2019-01-31
NCT03535987 Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy https://ClinicalTrials.gov/show/NCT03535987 Completed Abramson Cancer Center of the University of Pennsylvania 2019-04-19
NCT03511235 Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing https://ClinicalTrials.gov/show/NCT03511235 Completed Myriad Genetic Laboratories, Inc. 2018-07-31
NCT03503643 Hemi-Gland Cryoablation for Prostate Cancer at UCLA https://ClinicalTrials.gov/show/NCT03503643 Enrolling by invitation University of California, Los Angeles 2021-12-31
NCT03501173 A Study of Participants With Advanced Prostate Cancer in Canada https://ClinicalTrials.gov/show/NCT03501173 Recruiting Janssen Inc. 2021-04-30
NCT03502213 A Real World Study In Urology Practices Looking At The Impact Of The OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance https://ClinicalTrials.gov/show/NCT03502213 Completed Genomic Health®, Inc. 2018-06-30
NCT03503097 Genetic Testing for Men With Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT03503097 Recruiting University of Washington 2021-08-21
NCT03494803 Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC https://ClinicalTrials.gov/show/NCT03494803 Recruiting HKGepitherapeutics 2021-12-01
NCT03485794 Collection of Blood in Studying Metabolites in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03485794 Recruiting University of Southern California 2020-11-14
NCT03488706 Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level https://ClinicalTrials.gov/show/NCT03488706 Recruiting CellMaxLife 2018-12-12
NCT03475433 An Observational Prospective Cohort Study Using an Actigraphy Device. https://ClinicalTrials.gov/show/NCT03475433 Completed Taipei Medical University 2018-07-31
NCT03474913 Upright MRI for Prostate Cancer Screening https://ClinicalTrials.gov/show/NCT03474913 Recruiting Icahn School of Medicine at Mount Sinai 2024-08-01
NCT03442075 Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy https://ClinicalTrials.gov/show/NCT03442075 Completed Instituto Mexicano del Seguro Social 2017-07-31
NCT03424213 Race-related Alternative Splicing: Novel Targets in Prostate Cancer https://ClinicalTrials.gov/show/NCT03424213 Recruiting Duke University 2020-12-31
NCT03421015 Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution https://ClinicalTrials.gov/show/NCT03421015 Recruiting University Hospital, Lille 2020-07-31
NCT03414437 Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303) https://ClinicalTrials.gov/show/NCT03414437 Active, not recruiting Carolina Research Professionals, LLC 2021-10-01
NCT03419442 Multi-academic Center Study of Xofigo Patients https://ClinicalTrials.gov/show/NCT03419442 Completed Bayer 2019-10-22
NCT03413007 Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial https://ClinicalTrials.gov/show/NCT03413007 Recruiting Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2018-10-31
NCT01234350 A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON https://ClinicalTrials.gov/show/NCT01234350 Completed Ferring Pharmaceuticals 2018-03-27
NCT01233557 Biomarkers of Bone Resorption in Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT01233557 Completed University of Aberdeen 2014-08-31
NCT01226004 Multi-Institutional Registry for Prostate Cancer Radiosurgery https://ClinicalTrials.gov/show/NCT01226004 Recruiting Florida Robotic Radiosurgery Association 2020-07-31
NCT01215526 A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01215526 Completed Ferring Pharmaceuticals 2015-07-31
NCT01198457 Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment https://ClinicalTrials.gov/show/NCT01198457 Completed Bayer 2010-06-30
NCT01191099 Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance https://ClinicalTrials.gov/show/NCT01191099 Recruiting University of Zurich 2012-08-31
NCT01191931 Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) https://ClinicalTrials.gov/show/NCT01191931 Completed Advanced Medical Diagnostics s.a. NA
NCT01176526 The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis https://ClinicalTrials.gov/show/NCT01176526 Completed National Institutes of Health Clinical Center (CC) NA
NCT01160705 Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 https://ClinicalTrials.gov/show/NCT01160705 Active, not recruiting Cancer Trials Ireland 2017-09-19
NCT01123434 Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients. https://ClinicalTrials.gov/show/NCT01123434 Completed AstraZeneca 2014-08-31
NCT01120262 S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin https://ClinicalTrials.gov/show/NCT01120262 Completed Southwest Oncology Group 2010-07-31
NCT01098552 Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up https://ClinicalTrials.gov/show/NCT01098552 Completed Mayo Clinic 2012-11-30
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer https://ClinicalTrials.gov/show/NCT01081873 Completed Abbott 2010-12-31
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT01078545 Completed Abbott 2010-11-30
NCT01062503 Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC https://ClinicalTrials.gov/show/NCT01062503 Completed University Health Network, Toronto 2014-06-30
NCT01056562 An Alternative to A Fixed Schedule In Management Of Prostate Cancer https://ClinicalTrials.gov/show/NCT01056562 Completed University Health Network, Toronto 2014-06-30
NCT01025479 Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent https://ClinicalTrials.gov/show/NCT01025479 Completed AstraZeneca 2010-03-31
NCT01023529 Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers https://ClinicalTrials.gov/show/NCT01023529 Completed Sorlandet Hospital HF 2015-07-31
NCT01020604 PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients https://ClinicalTrials.gov/show/NCT01020604 Completed AstraZeneca 2013-03-31
NCT01013025 Vantas Implant Retrieval Study https://ClinicalTrials.gov/show/NCT01013025 Completed Endo Pharmaceuticals 2007-06-30
NCT01005225 Genetic Investigation of Solid Tumors Cohort https://ClinicalTrials.gov/show/NCT01005225 Completed Scripps Translational Science Institute 2014-05-31
NCT00992251 Eligard Observational Registry for Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00992251 Completed CMX Research 2014-03-31
NCT00991315 Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate https://ClinicalTrials.gov/show/NCT00991315 Active, not recruiting Rutgers, The State University of New Jersey 2021-05-31
NCT00984919 Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers https://ClinicalTrials.gov/show/NCT00984919 Completed Barbara Ann Karmanos Cancer Institute 2011-01-31
NCT00955435 Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 https://ClinicalTrials.gov/show/NCT00955435 Active, not recruiting Cancer Trials Ireland 2012-10-31
NCT00949819 Active Surveillance for Cancer of the Prostate (ASCaP) https://ClinicalTrials.gov/show/NCT00949819 Recruiting Jonsson Comprehensive Cancer Center 2020-06-04
NCT00937586 Prostate Cancer Prospective Cohort https://ClinicalTrials.gov/show/NCT00937586 Active, not recruiting Washington University School of Medicine 2025-06-30
NCT00930319 Effectiveness and Safety of Firmagon® https://ClinicalTrials.gov/show/NCT00930319 Completed Ferring Pharmaceuticals 2013-12-31
NCT00923416 Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events https://ClinicalTrials.gov/show/NCT00923416 Completed University Health Network, Toronto 2010-11-30
NCT00923221 Collection of Blood From Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00923221 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00923104 An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin https://ClinicalTrials.gov/show/NCT00923104 Completed National Institutes of Health Clinical Center (CC) NA
NCT00919477 Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg https://ClinicalTrials.gov/show/NCT00919477 Completed AstraZeneca 2012-03-31
NCT00908674 Androcur Effects on Quality of Life https://ClinicalTrials.gov/show/NCT00908674 Completed Bayer 2010-01-31
NCT00905086 Psychosocial Adjustment After Radiation Therapy in Patients With Cancer https://ClinicalTrials.gov/show/NCT00905086 Completed Case Comprehensive Cancer Center 2009-02-28
NCT00900185 Study of a Polymorphism in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00900185 Completed National Cancer Institute (NCI) NA
NCT00899912 Changes in DNA After Radiation Therapy in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00899912 Completed Radiation Therapy Oncology Group 2013-11-30
NCT00898326 PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer https://ClinicalTrials.gov/show/NCT00898326 Completed Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2016-12-31
NCT00899665 Proteases in Patients With Prostate Cancer That Has Spread to the Bone https://ClinicalTrials.gov/show/NCT00899665 Completed Barbara Ann Karmanos Cancer Institute 2006-09-30
NCT00899184 DNA Changes in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00899184 Completed Eastern Cooperative Oncology Group 2007-05-30
NCT00898274 Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants https://ClinicalTrials.gov/show/NCT00898274 Completed Case Comprehensive Cancer Center 2011-05-31
NCT00897793 Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer https://ClinicalTrials.gov/show/NCT00897793 Completed Vanderbilt-Ingram Cancer Center 2010-07-31
NCT00897351 Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 https://ClinicalTrials.gov/show/NCT00897351 Completed Eastern Cooperative Oncology Group 2009-02-10
NCT00893035 Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT00893035 Active, not recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2015-12-31
NCT00883909 ARI103094-Follow-Up Study for REDUCE Study Subjects https://ClinicalTrials.gov/show/NCT00883909 Completed GlaxoSmithKline 2010-12-01
NCT00874211 S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases https://ClinicalTrials.gov/show/NCT00874211 Completed Southwest Oncology Group 2019-06-30
NCT00871585 Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide https://ClinicalTrials.gov/show/NCT00871585 Completed AstraZeneca 2010-01-31
NCT00868803 Aberrant Gene Expression Prostate Carcinoma https://ClinicalTrials.gov/show/NCT00868803 Active, not recruiting Lahey Clinic 2020-04-30
NCT00850941 Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy https://ClinicalTrials.gov/show/NCT00850941 Active, not recruiting M.D. Anderson Cancer Center 2020-01-31
NCT04102904 The Prostate Liquid Study (PLiS) https://ClinicalTrials.gov/show/NCT04102904 Recruiting University College, London 2021-03-31
NCT03871816 A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer https://ClinicalTrials.gov/show/NCT03871816 Recruiting Janssen Research & Development, LLC 2021-07-26
NCT03241758 Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy https://ClinicalTrials.gov/show/NCT03241758 Completed Corporacion Parc Tauli 2017-08-02
NCT00828633 Health-Related Quality of Life in Gay Men With Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT00828633 Completed Baylor College of Medicine 2010-12-31
NCT00831142 Characterization of Prostate Cancer With 3T MR https://ClinicalTrials.gov/show/NCT00831142 Active, not recruiting Beth Israel Deaconess Medical Center 2012-01-31
NCT00822952 Prostate Mechanical Imager (PMI) Clinical Bridging Study https://ClinicalTrials.gov/show/NCT00822952 Completed Artann Laboratories 2009-09-30
NCT04017104 Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging https://ClinicalTrials.gov/show/NCT04017104 Recruiting British Columbia Cancer Agency 2022-08-01
NCT04122976 A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described https://ClinicalTrials.gov/show/NCT04122976 Recruiting Bayer 2025-01-30
NCT03604211 SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience https://ClinicalTrials.gov/show/NCT03604211 Completed Kantonsspital Graubuenden 2015-07-31
NCT03451812 Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer https://ClinicalTrials.gov/show/NCT03451812 Recruiting Chang Gung Memorial Hospital 2019-12-31
NCT03232411 Biobank for African American Prostate Cancer Research in Florida https://ClinicalTrials.gov/show/NCT03232411 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-12-31
NCT02269982 Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY https://ClinicalTrials.gov/show/NCT02269982 Completed Duke University 2017-09-01
NCT02450435 The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment https://ClinicalTrials.gov/show/NCT02450435 Completed Fuda Cancer Hospital, Guangzhou 2015-12-31
NCT00811876 Retrospective, Non-interventional Study of Depo-Eligard®. https://ClinicalTrials.gov/show/NCT00811876 Completed Astellas Pharma Inc 2009-12-31
NCT00807820 Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy https://ClinicalTrials.gov/show/NCT00807820 Completed University of California, San Francisco 2011-06-30
NCT03315260 Treatment Satisfaction With Ra-223 in Japan https://ClinicalTrials.gov/show/NCT03315260 Recruiting Bayer 2020-06-30
NCT02594202 Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue https://ClinicalTrials.gov/show/NCT02594202 Recruiting National Institutes of Health Clinical Center (CC) 2026-01-01
NCT04130776 4Kscore Using Serum Stored Uncentrifuged https://ClinicalTrials.gov/show/NCT04130776 Completed OPKO Health, Inc. 2018-03-27
NCT03851926 Hypofraccionated Radiotherapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT03851926 Recruiting Consorci Sanitari de Terrassa 2021-10-05
NCT03755492 Initiative to Minimize Disparities in Postoperative Prostate Cancer Care https://ClinicalTrials.gov/show/NCT03755492 Recruiting Albert Einstein Healthcare Network 2021-06-30
NCT03289130 Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness https://ClinicalTrials.gov/show/NCT03289130 Completed University of South Carolina 2009-08-31
NCT02858128 WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer https://ClinicalTrials.gov/show/NCT02858128 Completed Hospital Provincial de Castellon 2015-03-31
NCT01800058 Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy https://ClinicalTrials.gov/show/NCT01800058 Completed Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 2018-12-21
NCT01326286 Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT01326286 Completed Vanderbilt University Medical Center 2017-08-31
NCT01428869 Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer https://ClinicalTrials.gov/show/NCT01428869 Completed University Health Network, Toronto NA
NCT04278443 Fertility After Prostate Brachytherapy https://ClinicalTrials.gov/show/NCT04278443 Recruiting East and North Hertfordshire NHS Trust 2021-08-05
NCT04146077 Active Surveillance for Low Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT04146077 Recruiting I.M. Sechenov First Moscow State Medical University 2024-10-31
NCT00816452 Awareness to Osteopenia’s Treatment by Bisphosphonate in Male Suffering From Prostate Cancer https://ClinicalTrials.gov/show/NCT00816452 Completed Sanofi 2010-07-31
NCT00777452 A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT00777452 Completed Samsung Medical Center 2007-12-31
NCT00773656 Patients Overexposed for a Prostate Adenocarcinoma https://ClinicalTrials.gov/show/NCT00773656 Completed Assistance Publique - Hôpitaux de Paris 2013-05-31
NCT00773305 Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer https://ClinicalTrials.gov/show/NCT00773305 Completed Summa Health System 2010-11-30
NCT00769223 Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT00769223 Recruiting University of California, San Francisco 2025-01-31
NCT00800813 Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy https://ClinicalTrials.gov/show/NCT00800813 Completed Memorial Sloan Kettering Cancer Center 2014-07-31
NCT00763152 CMT-07-08: The PROstate Bed Evaluation Study https://ClinicalTrials.gov/show/NCT00763152 Completed Varian Medical 2009-08-31
NCT00754000 The AIM Study: Assessing the Impact of Margin Reduction https://ClinicalTrials.gov/show/NCT00754000 Completed Varian Medical NA
NCT00756665 Prostate Active Surveillance Study https://ClinicalTrials.gov/show/NCT00756665 Recruiting University of Washington 2024-09-30
NCT00733213 Depiction of Prostate Cancer Treatment Alternatives in Greece https://ClinicalTrials.gov/show/NCT00733213 Completed AstraZeneca NA
NCT00717613 Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting https://ClinicalTrials.gov/show/NCT00717613 Completed Baylor College of Medicine 2009-10-31
NCT00702104 Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area https://ClinicalTrials.gov/show/NCT00702104 Completed University of California, San Francisco 2008-01-31
NCT00692874 Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy https://ClinicalTrials.gov/show/NCT00692874 Completed AstraZeneca 2010-07-31
NCT00688532 Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not https://ClinicalTrials.gov/show/NCT00688532 Completed AstraZeneca 2009-06-30
NCT00662324 Development of a Clinical Trial Specific Question Prompt List https://ClinicalTrials.gov/show/NCT00662324 Completed Memorial Sloan Kettering Cancer Center 2013-05-31
NCT00651222 Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy https://ClinicalTrials.gov/show/NCT00651222 Completed Prostate Cancer Foundation of Chicago NA
NCT00636090 Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 https://ClinicalTrials.gov/show/NCT00636090 Completed Duke University 2009-12-31
NCT00632905 Bone Health Observational Study https://ClinicalTrials.gov/show/NCT00632905 Completed CMX Research 2016-03-31
NCT00590993 Magnetic Resonance Imaging and Spectroscopy of the Prostate https://ClinicalTrials.gov/show/NCT00590993 Completed Memorial Sloan Kettering Cancer Center 2013-02-28
NCT00584792 Diet, Genetic Variation and Prostate Cancer Among African Americans https://ClinicalTrials.gov/show/NCT00584792 Completed University of California, Davis 2007-12-31
NCT00581724 Pain in Cancer Survivors https://ClinicalTrials.gov/show/NCT00581724 Completed Memorial Sloan Kettering Cancer Center 2012-01-31
NCT00581672 Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men https://ClinicalTrials.gov/show/NCT00581672 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-12-31
NCT00581516 Molecular Urine Tests for Prostate Cancer https://ClinicalTrials.gov/show/NCT00581516 Completed University of California, Irvine 2008-09-30
NCT00580476 Assessing Depression in a Geriatric Cancer Population https://ClinicalTrials.gov/show/NCT00580476 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-12-31
NCT00579072 The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older https://ClinicalTrials.gov/show/NCT00579072 Recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT00579163 Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers https://ClinicalTrials.gov/show/NCT00579163 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT00578409 Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data https://ClinicalTrials.gov/show/NCT00578409 Completed Memorial Sloan Kettering Cancer Center 2010-04-30
NCT00582530 Men Undergoing Radical Prostatectomy https://ClinicalTrials.gov/show/NCT00582530 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-12-31
NCT00574899 Prostate Biomarker Study https://ClinicalTrials.gov/show/NCT00574899 Completed Memorial Sloan Kettering Cancer Center 2011-05-31
NCT00561444 Quality of Life Study for Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT00561444 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT00544336 Family Quality of Life Among Families With a Member Who is a Cancer Patient https://ClinicalTrials.gov/show/NCT00544336 Completed Vanderbilt-Ingram Cancer Center 2009-02-28
NCT00540059 Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial https://ClinicalTrials.gov/show/NCT00540059 Completed AstraZeneca NA
NCT00534196 Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT00534196 Active, not recruiting Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2016-11-30
NCT00535834 Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154 https://ClinicalTrials.gov/show/NCT00535834 Completed National Institutes of Health Clinical Center (CC) NA
NCT00523484 Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts https://ClinicalTrials.gov/show/NCT00523484 Completed AstraZeneca 2008-11-30
NCT00513721 Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy https://ClinicalTrials.gov/show/NCT00513721 Completed William Beaumont Hospitals 2009-05-31
NCT00507351 Ambulatory Cancer Pain Management: A Feasibility Study https://ClinicalTrials.gov/show/NCT00507351 Completed M.D. Anderson Cancer Center 2009-07-31
NCT00496249 The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT00496249 Completed University Health Network, Toronto 2008-01-31
NCT00499421 Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy https://ClinicalTrials.gov/show/NCT00499421 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT00490763 Active Surveillance in Prostate Cancer https://ClinicalTrials.gov/show/NCT00490763 Active, not recruiting M.D. Anderson Cancer Center 2020-02-29
NCT00489814 Study of Quality of Life for Prostate Proton Therapy https://ClinicalTrials.gov/show/NCT00489814 Active, not recruiting M.D. Anderson Cancer Center 2020-05-24
NCT00456144 Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT00456144 Completed Massachusetts General Hospital 2012-09-30
NCT00455624 Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT00455624 Completed Massachusetts General Hospital 2006-05-31
NCT00453661 Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities https://ClinicalTrials.gov/show/NCT00453661 Active, not recruiting M.D. Anderson Cancer Center 2022-03-31
NCT00444730 Urology Database for Outcomes Research https://ClinicalTrials.gov/show/NCT00444730 Completed William Beaumont Hospitals 2014-08-31
NCT00442000 Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy https://ClinicalTrials.gov/show/NCT00442000 Completed William Beaumont Hospitals 2009-12-31
NCT00433602 Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors https://ClinicalTrials.gov/show/NCT00433602 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-03-31
NCT00392938 Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone https://ClinicalTrials.gov/show/NCT00392938 Completed University of Washington 2010-05-31
NCT00339534 Survey of Prostate Cancer in Accra, Ghana https://ClinicalTrials.gov/show/NCT00339534 Completed National Institutes of Health Clinical Center (CC) 2020-05-15
NCT00376298 Urology Database to Evaluate Clinical Information and Improve Patient Care. https://ClinicalTrials.gov/show/NCT00376298 Completed William Beaumont Hospitals 2015-12-31
NCT00373308 Quality of Life Following Radical Prostatectomy https://ClinicalTrials.gov/show/NCT00373308 Active, not recruiting Stanford University 2020-07-31
NCT00373035 Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy https://ClinicalTrials.gov/show/NCT00373035 Completed Wake Forest University Health Sciences 2006-07-31
NCT00348465 Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds https://ClinicalTrials.gov/show/NCT00348465 Completed New York Methodist Hospital 2007-12-31
NCT00340717 Markers for Early Detection of Prostate Cancer https://ClinicalTrials.gov/show/NCT00340717 Completed National Institutes of Health Clinical Center (CC) NA
NCT00335634 Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery https://ClinicalTrials.gov/show/NCT00335634 Completed University Health Network, Toronto 2009-07-31
NCT00323388 Identification of Risk Allels for Prostate Cancer https://ClinicalTrials.gov/show/NCT00323388 Completed University of New Mexico 2007-09-30
NCT00323180 Investigation of Protein Biomarkers of Prostate Cancer https://ClinicalTrials.gov/show/NCT00323180 Completed University of New Mexico 2009-02-28
NCT00303914 Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00303914 Completed Eastern Cooperative Oncology Group 2008-03-31
NCT00292019 Robotic Laparoscopic Radical Prostatectomy https://ClinicalTrials.gov/show/NCT00292019 Completed Lawson Health Research Institute 2016-06-30
NCT00261456 The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer https://ClinicalTrials.gov/show/NCT00261456 Recruiting Institute of Cancer Research, United Kingdom 2020-02-29
NCT00264017 Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis https://ClinicalTrials.gov/show/NCT00264017 Completed Dattoli Cancer Center and Brachytherapy Research Institute NA
NCT00252460 CT/MRI Co-registration Prostate Cancer https://ClinicalTrials.gov/show/NCT00252460 Completed University Health Network, Toronto 2010-11-30
NCT00213694 PROSTACOX : Metastatic Prostate Chemotherapy https://ClinicalTrials.gov/show/NCT00213694 Completed University Hospital, Rouen NA
NCT00203918 Prostate Cancer Utilities and Cost-Effectiveness Analysis https://ClinicalTrials.gov/show/NCT00203918 Completed University of Chicago 2011-02-28
NCT00199537 Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer https://ClinicalTrials.gov/show/NCT00199537 Completed Lawson Health Research Institute 2008-02-29
NCT00186368 Microarray Analysis of Gene Expression in Prostate Tissues https://ClinicalTrials.gov/show/NCT00186368 Active, not recruiting Stanford University 2021-12-31
NCT00182624 Magnetic Resonance Imaging to Evaluate Prostate Cancer https://ClinicalTrials.gov/show/NCT00182624 Completed National Institutes of Health Clinical Center (CC) NA
NCT00176579 Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer https://ClinicalTrials.gov/show/NCT00176579 Completed Rutgers, The State University of New Jersey 2008-07-31
NCT00169676 Registry and Database Lap Prostatectomy https://ClinicalTrials.gov/show/NCT00169676 Completed Indiana Kidney Stone Institute 2016-04-30
NCT00126815 Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy https://ClinicalTrials.gov/show/NCT00126815 Completed AHS Cancer Control Alberta 2008-03-31
NCT00124410 Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation https://ClinicalTrials.gov/show/NCT00124410 Completed AHS Cancer Control Alberta 2008-12-31
NCT00087347 Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer https://ClinicalTrials.gov/show/NCT00087347 Completed Massachusetts General Hospital 2006-09-30
NCT00002924 Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy https://ClinicalTrials.gov/show/NCT00002924 Completed Alliance for Clinical Trials in Oncology 2006-06-30
NCT00052481 Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer https://ClinicalTrials.gov/show/NCT00052481 Completed Alliance for Clinical Trials in Oncology 2004-04-30
NCT00041301 Assessing Quality of Life of Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00041301 Completed European Organisation for Research and Treatment of Cancer - EORTC 2004-12-31
NCT00003329 Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer https://ClinicalTrials.gov/show/NCT00003329 Completed Eastern Cooperative Oncology Group 2007-12-31
NCT00001377 Familial Prostate Cancer https://ClinicalTrials.gov/show/NCT00001377 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041847 Gene-Environment Interaction in Prostate Cancer https://ClinicalTrials.gov/show/NCT00041847 Completed National Institute of Environmental Health Sciences (NIEHS) 2005-07-31
NCT00035217 Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program https://ClinicalTrials.gov/show/NCT00035217 Completed National Center for Research Resources (NCRR) NA
NCT00582842 Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT00582842 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT00668083 Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00668083 Completed AstraZeneca 2007-10-31
NCT00022919 Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods https://ClinicalTrials.gov/show/NCT00022919 Completed National Institutes of Health Clinical Center (CC) NA
NCT00342784 Identification of Prostate Cancer Genes https://ClinicalTrials.gov/show/NCT00342784 Completed National Institutes of Health Clinical Center (CC) NA
NCT00007579 To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. https://ClinicalTrials.gov/show/NCT00007579 Completed VA Office of Research and Development NA
NCT00007540 Study of Prostate Cancer in Black and White U.S. Veterans https://ClinicalTrials.gov/show/NCT00007540 Completed VA Office of Research and Development NA
NCT00001469 Genetic Analysis of Hereditary Prostate Cancer https://ClinicalTrials.gov/show/NCT00001469 Completed National Institutes of Health Clinical Center (CC) 2009-07-17
NCT00011349 Early Stage Prostate Cancer Cohort https://ClinicalTrials.gov/show/NCT00011349 Completed VA Office of Research and Development 2006-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03344835 Hong Kong Prostate Cancer Study Group Database https://ClinicalTrials.gov/show/NCT03344835 Recruiting Chinese University of Hong Kong 2035-12-31
NCT03340272 PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation. https://ClinicalTrials.gov/show/NCT03340272 Active, not recruiting Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2020-02-21
NCT03290508 Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT03290508 Recruiting Myriad Genetic Laboratories, Inc. 2022-09-30
NCT03284151 Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03284151 Recruiting Centre Francois Baclesse, Luxembourg 2020-01-31
NCT03235557 CyberKnife for Prostate Cancer Patients Aged 70 y or More https://ClinicalTrials.gov/show/NCT03235557 Active, not recruiting Centre Francois Baclesse, Luxembourg 2018-10-31
NCT03225222 MRI in PROstate Cancer Diagnosis With Prior Risk Assessment https://ClinicalTrials.gov/show/NCT03225222 Recruiting Erasmus Medical Center 2020-10-01
NCT03162523 Experiences With HDR-brachytherapy in Norway https://ClinicalTrials.gov/show/NCT03162523 Completed Oslo University Hospital 2016-10-15
NCT03152448 Prospective Prolaris Value and Efficacy https://ClinicalTrials.gov/show/NCT03152448 Active, not recruiting Myriad Genetic Laboratories, Inc. 2024-01-31
NCT03151629 Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN) https://ClinicalTrials.gov/show/NCT03151629 Recruiting Prostate Cancer Clinical Trials Consortium 2029-01-31
NCT03076242 Genetic Evaluation of Men (GEM) https://ClinicalTrials.gov/show/NCT03076242 Active, not recruiting Thomas Jefferson University 2021-01-31
NCT03075735 Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) https://ClinicalTrials.gov/show/NCT03075735 Completed Centro Nacional de Investigaciones Oncologicas CARLOS III 2018-05-31
NCT02971085 Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance https://ClinicalTrials.gov/show/NCT02971085 Recruiting Seoul National University Hospital 2022-01-31
NCT02869594 Institut Paoli Calmettes Prostate Cancer Database https://ClinicalTrials.gov/show/NCT02869594 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02865330 Spanish Urological Association Registry of Patients on Active Surveillance https://ClinicalTrials.gov/show/NCT02865330 Recruiting Fundación Instituto Valenciano de Oncología 2019-06-30
NCT02803437 Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases https://ClinicalTrials.gov/show/NCT02803437 Active, not recruiting Bayer 2020-11-30
NCT02516709 Linear Source Registry for Prostate Cancer https://ClinicalTrials.gov/show/NCT02516709 Recruiting CivaTech Oncology 2020-08-31
NCT02425228 Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer https://ClinicalTrials.gov/show/NCT02425228 Completed Jonsson Comprehensive Cancer Center 2018-12-18
NCT02381990 Fuse Image MRI Guided Prostate Cryotherapy https://ClinicalTrials.gov/show/NCT02381990 Recruiting Urological Research Network, LLC 2019-06-30
NCT02255890 Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device https://ClinicalTrials.gov/show/NCT02255890 Recruiting Clinical Research Office of the Endourological Society 2019-12-31
NCT02209584 Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT02209584 Completed Myriad Genetic Laboratories, Inc. 2015-04-15
NCT02156414 Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT02156414 Completed Javeriana University 2014-08-31
NCT01954004 Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients https://ClinicalTrials.gov/show/NCT01954004 Completed Myriad Genetic Laboratories, Inc. 2014-09-30
NCT01861236 Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina https://ClinicalTrials.gov/show/NCT01861236 Completed Ferring Pharmaceuticals 2018-09-03
NCT01813370 A Registry for Patients Treated on the Clinical Trial TAX 3503 https://ClinicalTrials.gov/show/NCT01813370 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT04404894 Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing https://ClinicalTrials.gov/show/NCT04404894 Recruiting Myriad Genetic Laboratories, Inc. 2021-11-30
NCT04292041 Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome https://ClinicalTrials.gov/show/NCT04292041 Active, not recruiting Galway Clinic 2020-06-15
NCT04228211 Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation https://ClinicalTrials.gov/show/NCT04228211 Recruiting UMC Utrecht 2023-02-05
NCT04100811 Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinelâ„¢ Platform https://ClinicalTrials.gov/show/NCT04100811 Recruiting miR Scientific LLC 2021-12-15
NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study https://ClinicalTrials.gov/show/NCT04075305 Recruiting UMC Utrecht 2024-02-01
NCT04052048 Active Surveillance SNEP Assay Registry Trial for Prostate Cancer https://ClinicalTrials.gov/show/NCT04052048 Recruiting OncoCell MDX 2020-09-30
NCT04034095 A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan https://ClinicalTrials.gov/show/NCT04034095 Recruiting Janssen Pharmaceutical K.K. 2024-07-15
NCT04024475 Prostate Cancer Biobank https://ClinicalTrials.gov/show/NCT04024475 Recruiting Swiss Group for Clinical Cancer Research 2022-12-31
NCT04015102 A Registry for Hereditary Cancer Risk Assessment and Genetic Testing https://ClinicalTrials.gov/show/NCT04015102 Recruiting Myriad Genetic Laboratories, Inc. 2022-03-06
NCT03961321 Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer https://ClinicalTrials.gov/show/NCT03961321 Completed VU University Medical Center 2019-04-17
NCT03790995 Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP https://ClinicalTrials.gov/show/NCT03790995 Completed KU Leuven 2016-02-29
NCT03770351 Early Prostate Cancer: Predicting Treatment Response https://ClinicalTrials.gov/show/NCT03770351 Active, not recruiting University of California, Irvine 2019-06-30
NCT03619980 A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death https://ClinicalTrials.gov/show/NCT03619980 Completed Astellas Pharma Inc 2018-11-28
NCT03553732 An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital https://ClinicalTrials.gov/show/NCT03553732 Active, not recruiting University of California, San Francisco 2020-06-30
NCT03516110 Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy https://ClinicalTrials.gov/show/NCT03516110 Completed Ipsen 2020-02-28
NCT03447028 Effect of TyG Index on Outcomes of Radical Prostatectomy https://ClinicalTrials.gov/show/NCT03447028 Completed Recep Tayyip Erdogan University Training and Research Hospital 2012-12-30
NCT03214055 Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy https://ClinicalTrials.gov/show/NCT03214055 Completed Asan Medical Center 2017-08-14
NCT02609269 Decipher Genomics Resource Information Database https://ClinicalTrials.gov/show/NCT02609269 Enrolling by invitation GenomeDx Biosciences Corp 2020-12-31
NCT02546908 A Registry of Participants With Prostate Cancer in Asia https://ClinicalTrials.gov/show/NCT02546908 Active, not recruiting Janssen Research & Development, LLC 2020-09-07